<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29670542</article-id>
<article-id pub-id-type="pmc">5893901</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2018.00329</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>ATP Synthase Diseases of Mitochondrial Genetic Origin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dautant</surname>
<given-names>Alain</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/534728/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meier</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/212935/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hahn</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tribouillard-Tanvier</surname>
<given-names>Déborah</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>di Rago</surname>
<given-names>Jean-Paul</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kucharczyk</surname>
<given-names>Roza</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c003">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/542395/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institut de Biochimie et Génétique Cellulaires, Centre National de la Recherche Scientifique UMR 5095, Université de Bordeaux</institution>, <addr-line>Bordeaux</addr-line>, <country>France</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Life Sciences, Imperial College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Structural Biology, Max-Planck-Institute of Biophysics</institution>, <addr-line>Frankfurt</addr-line>, <country>Germany</country></aff>
<aff id="aff4"><sup>4</sup><institution>Institute of Biochemistry and Biophysics, Polish Academy of Sciences</institution>, <addr-line>Warsaw</addr-line>, <country>Poland</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Paolo Bernardi, Università degli Studi di Padova, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Diego Gonzalez Halphen, Universidad Nacional Autónoma de México, Mexico; Ilka Wittig, Goethe Business School, Germany</p>
</fn>
<corresp id="c001">*Correspondence: Thomas Meier <email>t.meier@imperial.ac.uk</email></corresp>
<corresp id="c002">Jean-Paul di Rago <email>jp.dirago@ibgc.cnrs.fr</email></corresp>
<corresp id="c003">Roza Kucharczyk <email>roza@ibb.waw.pl</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Mitochondrial Research, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>329</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Dautant, Meier, Hahn, Tribouillard-Tanvier, di Rago and Kucharczyk.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Dautant, Meier, Hahn, Tribouillard-Tanvier, di Rago and Kucharczyk</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Devastating human neuromuscular disorders have been associated to defects in the ATP synthase. This enzyme is found in the inner mitochondrial membrane and catalyzes the last step in oxidative phosphorylation, which provides aerobic eukaryotes with ATP. With the advent of structures of complete ATP synthases, and the availability of genetically approachable systems such as the yeast <italic>Saccharomyces cerevisiae</italic>, we can begin to understand these molecular machines and their associated defects at the molecular level. In this review, we describe what is known about the clinical syndromes induced by 58 different mutations found in the mitochondrial genes encoding membrane subunits <italic>8</italic> and <italic>a</italic> of ATP synthase, and evaluate their functional consequences with respect to recently described cryo-EM structures.</p>
</abstract>
<kwd-group>
<kwd>mitochondrial diseases</kwd>
<kwd>F<sub>1</sub>F<sub>o</sub> ATP synthase structure</kwd>
<kwd>mitochondrial DNA (mtDNA)</kwd>
<kwd>MT-ATP6</kwd>
<kwd>MT-ATP8</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Association Française contre les Myopathies<named-content content-type="fundref-id">10.13039/100007393</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">Agence Nationale de la Recherche<named-content content-type="fundref-id">10.13039/501100001665</named-content></funding-source>
<award-id rid="cn002">ANR-12-BSV8-024</award-id>
</award-group>
<award-group>
<funding-source id="cn003">National Science Center of Poland</funding-source>
<award-id rid="cn003">UMO-2016/23/B/NZ3/02098</award-id>
</award-group>
<award-group>
<funding-source id="cn004">Wellcome Trust<named-content content-type="fundref-id">10.13039/100004440</named-content></funding-source>
<award-id rid="cn004">WT110068/Z/15/Z</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="148"></ref-count>
<page-count count="16"></page-count>
<word-count count="11988"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Mitochondria support aerobic respiration and produce the bulk of cellular ATP by oxidative phosphorylation (OXPHOS) (Saraste, <xref ref-type="bibr" rid="B109">1999</xref>). Electrons provided by the oxidation of fatty acids and carbohydrates are shuttled to oxygen along four respiratory chain (RC) complexes (I–IV) embedded in the inner mitochondrial membrane (IMM), producing water and releasing the energy necessary to pump protons from the mitochondrial matrix to the intermembrane space (IMS). This results in the formation of transmembrane electrochemical ion gradient across the IMM, also called the proton-motive force (<italic>pmf</italic>). The outer side of the IMM is positively charged (the <italic>p</italic>-side) while the inner side is negatively charged (the <italic>n</italic>-side). The <italic>pmf</italic> enables the F<sub>1</sub>F<sub>o</sub> ATP synthase to produce ATP from ADP and inorganic phosphate (Boyer, <xref ref-type="bibr" rid="B11">1997</xref>). The OXPHOS complexes contain ~90 structural proteins of which 13 are encoded by the mtDNA in humans.</p>
<p>More than 150 distinct genetic mitochondrial dysfunction syndromes characterized by a diminished OXPHOS capacity have been described (Tuppen et al., <xref ref-type="bibr" rid="B132">2010</xref>; Hejzlarova et al., <xref ref-type="bibr" rid="B41">2014</xref>; Chinnery, <xref ref-type="bibr" rid="B18">2015</xref>; Ng and Turnbull, <xref ref-type="bibr" rid="B84">2015</xref>; Stewart and Chinnery, <xref ref-type="bibr" rid="B121">2015</xref>; Xu et al., <xref ref-type="bibr" rid="B145">2015</xref>). These diseases affect at least 1 in 5,000 live human births (Skladal et al., <xref ref-type="bibr" rid="B118">2003</xref>). Typical clinical traits include visual/hearing defects, encephalopathies, cardiomyopathies, myopathies, diabetes, liver, and renal dysfunctions (Table <xref ref-type="table" rid="T1">1</xref>; Dimauro and Schon, <xref ref-type="bibr" rid="B26">2003</xref>; Zeviani and Carelli, <xref ref-type="bibr" rid="B147">2007</xref>; Vafai and Mootha, <xref ref-type="bibr" rid="B135">2012</xref>). Many known cases result from alterations in mtDNA (~15%, e.g., NARP, MILS, LHON), which occur as a result of this DNA's high susceptibility to mutations because of the nearby ROS production and the poor effectiveness of the mitochondrial DNA repair system (Wallace, <xref ref-type="bibr" rid="B141">2010</xref>). More than 600 different point mutations and innumerable large-scale rearrangements of mtDNA have been implicated in human diseases (Lott et al., <xref ref-type="bibr" rid="B71">2013</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Diseases and syndromes caused by mutations in ATP8 and ATP6.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease/Syndrome</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotypes</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Apical hypertrophic cardiomyopathy (AHCM) and neuropathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">primary disease of the myocardium (the muscle of the heart) in which a portion of the myocardium is hypertrophied (thickened) without any obvious cause, creating functional impairment of the cardiac muscle; neuropathy is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia</td>
<td align="left" colspan="1" rowspan="1" valign="top">genetic disorders characterized by slowly progressive incoordination of gait and is often associated with poor coordination of hands, speech, and eye movements, with full mental capacity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurodevelopmental disorder, characterized by impaired social interaction, verbal and non-verbal communication, and restricted and repetitive behavior; noticeably affected by mitochondrial dysfunction which impairs energy metabolism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Charcot-Marie-Tooth syndrome (CMT)</td>
<td align="left" colspan="1" rowspan="1" valign="top">hereditary disorders that damage the nerves in arms and legs (peripheral nerves); symptoms usually begin in feet and legs, but they may eventually affect hands and arms</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Encephalopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">abnormal brain function or brain structure, symptoms may be mental or physical dysfunctions, depending on what part of the brain is being affected</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy with Brain Pseudoatrophy</td>
<td align="left" colspan="1" rowspan="1" valign="top">brain disorder manifesting by seizures, dementia, convulsions, loss of control on muscles, difficulties with talking</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Episodic Weakness</td>
<td align="left" colspan="1" rowspan="1" valign="top">muscular disorders (myopathies) that are only present after exercise or are exacerbated by exercise, skeletal muscle diseases, may be accompanied by neurological symptoms</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hereditary Spastic Paraplegia (HSP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">heterogeneous disorder characterized by lower extremity spasticity and weakness</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Familial Bilateral Striatal Necrosis (FBSN)</td>
<td align="left" colspan="1" rowspan="1" valign="top">acute neurological syndrome associated with radiological findings, respiratory illnesses presenting with an array of neurological findings, including axial ataxia, grimacing, mutism, head nodding, and high-pitched cry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile cardiomyopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">severe, eventually fatal, cardiac arrhythmias, characterized pathologically by cardiac hypertrophy and by a distinctive type of focal degeneration of the muscle cells, which lose their myofibrils, undergo marked mitochondrial hyperplasia, become rounded in shape and enlarged, and resemble histiocytes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Leber Hereditary Optic Neuropathy (LHON)</td>
<td align="left" colspan="1" rowspan="1" valign="top">maternally inherited disease leading to acute bilateral blindness due to loss of the optic nerve and papillomacular bundle nerve fibers, predominantly in young men</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Left Ventricular HyperTrabeculation syndrome (LVHT) (noncompaction)</td>
<td align="left" colspan="1" rowspan="1" valign="top">myocardial abnormality of the apex, characterized by multiple, myocardial cotyledo-like protrusions and interwoven strings, all lined by endocardium; in three quarters of the cases associated with neuromuscular disorders</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Maternally Inherited Diabetes and Deafness syndrome (MIDD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">form of diabetes that is often accompanied by hearing loss, especially of high tones, characterized by high blood sugar levels (hyperglycemia) resulting from a shortage of the hormone insulin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Maternally Inherited Leigh Syndrome (MILS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">early-onset progressive neurodegenerative disorder with a characteristic neuropathology consisting of focal, bilateral lesions in one or more areas of the central nervous system, manifesting with (encephalopathy), lactic acidosis, seizures, heart disease (cardiomyopathy), breathing (respiratory) abnormalities, and developmental delays</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mesial Temporal Lobe Epilepsies with Hippocampal Sclerosis (MTLE-HS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">chronic neurological condition characterized by recurrent, unprovoked epileptic seizures (epilepsy) which originate in the temporal lobe of the brain, its pathophysiological substrate is usually hippocampal sclerosis, the most common epileptogenic lesion encountered in patients with epilepsy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Metabolic Syndrome (MS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">disorder characterized by a group of metabolic abnormalities including hyperglycemia, hypertension, hyperlipaemia and central obesity, which are the risk factors of cardiovascular disease and diabetes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Motor Neuron Syndrome (MNS)</td>
<td align="left" colspan="1" rowspan="1" valign="top">cognitive impairment, exercise intolerance, and progressive muscle weakness</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Myopathy, Lactic Acidosis, and Sideroblastic Anemia (MLASA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">mitochondrial disorder specific to skeletal muscle and bone marrow with myopathy, lactic acidosis, and sideroblastic anemia with ringed sideroblasts</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurogenic Ataxia Retinis Pigmentosa syndrome (NARP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">mitochondrial disease affecting nervous system manifesting with pain in the arms and legs (sensory neuropathy), muscle weakness, problems with balance and coordination (ataxia), vision loss caused by retinitis pigmentosa or changes in the light-sensitive tissue that lines the back of the eye</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Periodic paralyzes</td>
<td align="left" colspan="1" rowspan="1" valign="top">genetic diseases that lead to weakness or paralysis (rarely death) from common triggers such as cold, heat, high carbohydrate meals, not eating, stress or excitement, and physical activity of any kind</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">mental disorder, often characterized by abnormal social behavior and failure to recognize what is real</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SpinoCerebellar Ataxia (SCA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ataxia that is due to dysfunction of the cerebellum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tetralogy of Fallot (ToF)</td>
<td align="left" colspan="1" rowspan="1" valign="top">type of congenital heart disease, essentially a right-sided heart disease, with characteristic features of ventricular septal defect, right ventricular outflow tract obstruction, aortic dextroposition, and right ventricular hypertrophy</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>This review focuses on mutations in the MT-ATP8 and MT-ATP6 genes (further named ATP8 and ATP6) encoding subunits <italic>8</italic> and <italic>a</italic> of ATP synthase, respectively, that were identified in patients with various disorders. We summarize what is known about their clinical and functional consequences. Based on recent high-resolution structures (Morales-Rios et al., <xref ref-type="bibr" rid="B79">2015a</xref>; Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>; Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>), we define the topological locations of these mutations, which helps understand their impact on ATP synthase structure, function and assembly.</p>
</sec>
<sec id="s2">
<title>ATP synthase structure and function</title>
<p>Mitochondrial ATP synthase is a unique macromolecular rotary machine of ~625 kDa. It is composed of typically 17 different protein subunits (Figure <xref ref-type="fig" rid="F1">1</xref>) and organizes into a membrane-extrinsic F<sub>1</sub> catalytic and membrane-embedded F<sub>o</sub> domains, which are connected by a peripheral and central stalk (Allegretti et al., <xref ref-type="bibr" rid="B4">2015</xref>; Morales-Rios et al., <xref ref-type="bibr" rid="B79">2015a</xref>; Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>). The matrix-oriented F<sub>1</sub> is composed of a prominent (αβ)<sub>3</sub> catalytic head into which the γ<italic>δε</italic> central stalk rotor penetrates. The F<sub>o</sub>
<italic>c</italic>-ring typically consists of identical <italic>c</italic> subunits (subunit <italic>9</italic> in yeast). Together with subunit <italic>a</italic>, the <italic>c</italic>-ring shuttles protons across the membrane. The F<sub>o</sub> domain further consists of subunits <italic>8</italic> (alias <italic>A6L</italic>), <italic>b (4</italic> in yeast<italic>), f</italic>, <italic>d, F6</italic> (<italic>h</italic> in yeast), and <italic>OSCP</italic> that together form the peripheral stalk connecting the catalytic head with the membrane stator. Three mitochondria-specific subunits, <italic>e, g, k</italic>, induce either directly or indirectly the formation of ATP synthase dimers (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>) that self-assemble in longer ribbons important for cristae formation (Parsons, <xref ref-type="bibr" rid="B90">1963</xref>; Strauss et al., <xref ref-type="bibr" rid="B122">2008</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Cartoon representation of the yeast F<sub>1</sub>F<sub>o</sub> ATP synthase. The view is horizontally to the membrane shown in grayscale. The structure was drawn according to (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>, PDB code 5FL7). For simplicity the structure is shown without subunits <italic>e, f</italic>, <italic>g, I</italic>, and a truncated subunit <italic>b</italic>. The figure was made in Pymol (The PyMOL Molecular Graphics System, Version 0.99, Schrödinger, LLC), using the following color code: α, forest; β, split pea; γ, density; δ, cyan; ε, white; <italic>OSCP</italic>, red; <italic>b</italic> (= <italic>4</italic> in yeast), dirty violet; <italic>d</italic>, orange; <italic>h</italic>, salmon; <italic>8</italic>, green; <italic>a</italic>, blue; <italic>c</italic>-ring, yellow. The arrows indicate the path of protons (see also Figure <xref ref-type="fig" rid="F4">4</xref>) and nucleotide conversion. For details see text.</p>
</caption>
<graphic xlink:href="fphys-09-00329-g0001"></graphic>
</fig>
<p>The ATP synthase harbors a unique rotary mechanism driven by the <italic>pmf</italic> to translocate ions through F<sub>o</sub>, to generate rotation of its rotor and transmit torque into the F<sub>1</sub> catalytic head where finally ATP is synthesized and released. Subunit <italic>a</italic> provides a pathway that involves a number of hydrophilic amino acids, which allows protons to enter from the IMS (Figure <xref ref-type="fig" rid="F1">1</xref>). Approximately in the middle of the membrane the proton can bind to a highly conserved acidic residue of subunit <italic>c</italic> helix 2 (<italic>c</italic>H2) (<italic>c</italic>E59 in <italic>H. sapiens</italic>) located at the outer surface of the <italic>c</italic>-ring. It has been suggested that the binding of a proton on this carboxylate residue disrupts a previously established electrostatic interaction of <italic>c</italic>E59 with a highly conserved, positively charged arginine residue in subunit <italic>a</italic> membrane helix 5 (<italic>a</italic>H5) (<italic>a</italic>R159 in <italic>H. sapiens</italic>; Vik and Antonio, <xref ref-type="bibr" rid="B139">1994</xref>; Junge et al., <xref ref-type="bibr" rid="B53">1997</xref>; Pogoryelov et al., <xref ref-type="bibr" rid="B97">2010</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). This arginine acts as an electrostatic separator between the proton pathway from the IMS to the middle of the membrane and a second, spatially separated pathway that allows incoming protons still bound on the <italic>c</italic>-ring glutamate to be released into the matrix (Mitome et al., <xref ref-type="bibr" rid="B77">2010</xref>). The operation direction of this process is primarily driven by the ion gradient that causes a ratchet type mechanism of the neutralized <italic>c</italic>-ring glutamate in the hydrophobic membrane, which is energetically unfavorable and does not allow the back stepping without externally applied force (Vik and Antonio, <xref ref-type="bibr" rid="B139">1994</xref>; Junge et al., <xref ref-type="bibr" rid="B53">1997</xref>). After an almost complete revolution of the <italic>c</italic>-ring, the glutamate is deprotonated in the aqueous exit channel (Pogoryelov et al., <xref ref-type="bibr" rid="B97">2010</xref>). This channel is formed by hydrophilic residues of the <italic>c</italic>-ring/subunit <italic>a</italic> interface at the matrix side through which the protons can reach the matrix (<italic>n</italic>-Side) (Allegretti et al., <xref ref-type="bibr" rid="B4">2015</xref>; Morales-Rios et al., <xref ref-type="bibr" rid="B79">2015a</xref>; Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>; Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). The <italic>c</italic>-ring is tightly bound to the central stalk subunits γ<italic>δε</italic>, of which subunit γ protrudes into the F<sub>1</sub> catalytic head, which induces cyclic conformational changes when rotating (Abrahams et al., <xref ref-type="bibr" rid="B1">1994</xref>). Consequently, ADP and P<sub>i</sub> are sequentially converted at the catalytic sites of the three subunits β, according to the binding change mechanism (Boyer, <xref ref-type="bibr" rid="B11">1997</xref>). Cryo-EM structures of the bovine <italic>Bos taurus</italic> and yeasts <italic>Yarrowia lipolytica</italic> and <italic>Saccharomyces cerevisiae</italic> F<sub>1</sub>F<sub>o</sub> ATP synthases, that are basically of the same subunit composition and structural construction as the human enzyme, have been described recently [15–17]. These structures show a very similar overall architecture and differ only with respect to the subunit <italic>c</italic> (<italic>9</italic>) stoichiometry (8 in mammals, 10 in yeasts), the loss of the dimerization domain subunits (<italic>e</italic>/<italic>g</italic>/<italic>k</italic>) during purification (yeast) and the non-essential and yeast specific subunits <italic>i</italic> and <italic>k</italic> (Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>; Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). It therefore has become feasible to build reliable structural models of the membrane domain (F<sub>o</sub>) of the eukaryotic, mitochondrial, ATP synthase (Figure <xref ref-type="fig" rid="F1">1</xref>), and to map the human disease-causing mutations at the molecular level within the ATP synthase structure and to pin-point their potentially adverse effects on the above-described mechanism.</p>
</sec>
<sec id="s3">
<title>Yeast and human cellular models of mtDNA diseases</title>
<p>Human cells contain up to thousands copies of mtDNA (Miller et al., <xref ref-type="bibr" rid="B76">2003</xref>). Mutations in this DNA are highly recessive and usually co-exist with wild type mtDNA molecules, a situation referred to as heteroplasmy. A mutational load above 60% is usually required to induce a clinical phenotype (Stewart and Chinnery, <xref ref-type="bibr" rid="B121">2015</xref>). Given the high mutational rate of the mitochondrial genome and the presence of numerous family or population-specific polymorphisms, it can be difficult to distinguish between a neutral mtDNA variant and a disease-causing mutation. Additionally, the effects of deleterious mtDNA mutations might be exacerbated by mtDNA nucleotide changes that are not pathogenic <italic>per se</italic> and by unknown factors in nuclear genetic background, i.e., the so-called modifier genes (Cai et al., <xref ref-type="bibr" rid="B14">2008</xref>; Swalwell et al., <xref ref-type="bibr" rid="B123">2008</xref>). These features make it difficult from patient's cells and tissues to precisely know how specific mtDNA mutations influence oxidative phosphorylation.</p>
<p>To better characterize the effects of mtDNA mutations, homoplasmic cell lines, i.e. with a 100% mutational load, in a defined nuclear genetic background are required. To this end King and Attardi (King and Attardi, <xref ref-type="bibr" rid="B56">1989</xref>) developed an approach that used cybrid (cytoplasmic hybrid) cell lines obtained by fusing enucleated cytoplasts from patient's cells with cells lacking mtDNA (ρ<sup>0</sup>). This approach was used to evaluate the bioenergetics consequences of 11 ATP6 mutations (Trounce et al., <xref ref-type="bibr" rid="B130">1994</xref>; Majander et al., <xref ref-type="bibr" rid="B72">1997</xref>; Nijtmans et al., <xref ref-type="bibr" rid="B86">2001</xref>; Carrozzo et al., <xref ref-type="bibr" rid="B15">2004</xref>; Mattiazzi et al., <xref ref-type="bibr" rid="B75">2004</xref>; Pallotti et al., <xref ref-type="bibr" rid="B89">2004</xref>; Jonckheere et al., <xref ref-type="bibr" rid="B51">2008</xref>; Sikorska et al., <xref ref-type="bibr" rid="B117">2009</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref>; Blanco-Grau et al., <xref ref-type="bibr" rid="B9">2013</xref>; Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref>; Hejzlarova et al., <xref ref-type="bibr" rid="B40">2015</xref>; Wen et al., <xref ref-type="bibr" rid="B144">2016</xref>). Another approach exploits unique features of <italic>S. cerevisiae</italic>. Mitochondria from this single-celled fungus and humans show many similarities (Steinmetz et al., <xref ref-type="bibr" rid="B120">2002</xref>; Prokisch et al., <xref ref-type="bibr" rid="B99">2004</xref>; Reinders et al., <xref ref-type="bibr" rid="B102">2006</xref>; Pagliarini et al., <xref ref-type="bibr" rid="B88">2008</xref>; Rhee et al., <xref ref-type="bibr" rid="B103">2013</xref>), and mitochondrial genetic transformation can be achieved in this yeast in a highly controlled fashion, by the biolistic delivery into mitochondria of <italic>in-vitro</italic>-made mutated mtDNA fragments, followed by their integration into wild type mtDNA by homologous DNA recombination (Bonnefoy and Fox, <xref ref-type="bibr" rid="B10">2001</xref>). Being unable to stably maintain heteroplasmy (Okamoto et al., <xref ref-type="bibr" rid="B87">1998</xref>), it is easy to obtain yeast homoplasmic populations where all mtDNA molecules carry a mutation of interest. Owing to its good fermenting capacity, yeast models of human mitochondrial diseases can be kept alive when provided with sugars like glucose even when oxidative phosphorylation is completely inactivated (Baile and Claypool, <xref ref-type="bibr" rid="B6">2013</xref>; Lasserre et al., <xref ref-type="bibr" rid="B68">2015</xref>). This approach was used to investigate the impact on ATP synthase of nine ATP6 mutations identified in patients (Rak et al., <xref ref-type="bibr" rid="B101">2007</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B60">2009a</xref>,<xref ref-type="bibr" rid="B61">b</xref>,<xref ref-type="bibr" rid="B62">c</xref>, <xref ref-type="bibr" rid="B58">2010</xref>, <xref ref-type="bibr" rid="B59">2013</xref>; Kabala et al., <xref ref-type="bibr" rid="B54">2014</xref>; Lasserre et al., <xref ref-type="bibr" rid="B68">2015</xref>; Niedzwiecka et al., <xref ref-type="bibr" rid="B85">2016</xref>; Wen et al., <xref ref-type="bibr" rid="B144">2016</xref>).</p>
</sec>
<sec id="s4">
<title>Pathogenic mutations in ATP8 and ATP6</title>
<p>Subunits <italic>8</italic> and <italic>a</italic> are synthesized from a bi-cistronic mRNA unit (Figure <xref ref-type="fig" rid="F2">2</xref>). The two genes show a 46 nucleotide overlap. Thus, mutations in this unit can affect either subunit <italic>a</italic> or <italic>8</italic>, or both. Currently, 36 different ATP8 and ATP6 mutations with a confirmed or suspected pathogenic character are recorded in MITOMAP database (Figure <xref ref-type="fig" rid="F3">3</xref>). We here review 22 additional mutations found in literature. The nucleotide and amino acid changes induced by these mutations, and what is known about their functional and clinical consequences is summarized in Table <xref ref-type="table" rid="T2">2</xref>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>ATP6 and ATP8 genes and sites of pathogenic mutations. The two coding sequences overlap, between positions 8527 and 8572 (cyan) of the human mitochondrial genome. Start and end nucleotide numbers are indicated. The number of mutations (m) identified in patients and their positions are indicated. These mutations are listed in Table <xref ref-type="table" rid="T2">2</xref>.</p>
</caption>
<graphic xlink:href="fphys-09-00329-g0002"></graphic>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Sequence alignment of subunits <italic>a, b</italic> and <italic>8</italic> from a selected range of species. <bold>(A)</bold> Alignment of bacterial subunits <italic>b</italic> (<italic>b</italic>′ or <italic>b2</italic> isoform) and mitochondrial subunits <italic>8</italic>. The sequences of subunit <italic>b</italic> are from <italic>Rhodobacter sphaeroides</italic> (<italic>R.s</italic>.)<italic>, Ruegeria</italic> sp. (<italic>R.sp</italic>)<italic>, Roseobacter denitrificans</italic> (<italic>R.d</italic>.), <italic>Jannaschia</italic> sp. (<italic>J.sp</italic>) <italic>and Dinoroseobacter shibae</italic> (<italic>D.s</italic>.). The length of N- and C-termini extensions are given. The sequences of subunit <italic>8</italic> are from a selection of mammals and the yeast species <italic>Schizosaccharomyces pombe (S.p.), Podospora anserina (P.a.), Yarrowia lipolytica</italic> (<italic>Y.l</italic>.)<italic>, Saccharomyces cerevisiae</italic> (<italic>S.c</italic>.) and <italic>Candida glabrata</italic> (<italic>C.g</italic>.). <bold>(B)</bold> Alignment of subunit <italic>a</italic>. <italic>Homo sapiens (H.s.), Bos taurus</italic> (<italic>B.t</italic>.). The sequences corresponding to overlapping ATP8 and ATP6 genes are marked in cyan as in Figure <xref ref-type="fig" rid="F2">2</xref>. Peptide sequences removed in the mature form of yeast subunit <italic>a</italic> are marked in yellow. At the top and bottom, the arrows mark the locations of the human mutations (Table <xref ref-type="table" rid="T2">2</xref>) and the mutations modeled in <italic>S</italic>.c., respectively. The arrows are colored according to Figure <xref ref-type="fig" rid="F4">4</xref>. At the bottom, the secondary structural elements are drawn according to PSIPRED prediction (2D) and a cryo-EM structure (3D) (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>).</p>
</caption>
<graphic xlink:href="fphys-09-00329-g0003"></graphic>
</fig>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Pathogenic mutations in ATP8 and ATP6 genes, associated disease(s)/syndrome(s), number of cases (N), patient's age (year), heteroplasmy (H), pathogenicity (PG), and ATP synthase activities and mitochondrial morphology.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top"><bold>mtDNA mutation, m</bold>.</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Protein mutation</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease(s) syndrome(s)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>N</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Age (y)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>H %</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>ATP synthase</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>ROS/Mitochondria morphology</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>PG</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Activity</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Assembly/Stability</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8381A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>T6A</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIDD, LVHT</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">38,57</td>
<td align="center" colspan="1" rowspan="1" valign="top">99</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Perucca-Lostanlen et al., <xref ref-type="bibr" rid="B92">2000</xref>; Finsterer et al., <xref ref-type="bibr" rid="B31">2004</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8393C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>P10S</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy with brain pseudoatrophy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;99</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Galimberti et al., <xref ref-type="bibr" rid="B33">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8403T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>I13T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Episodic weakness</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">8</td>
<td align="center" colspan="1" rowspan="1" valign="top">99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aure et al., <xref ref-type="bibr" rid="B5">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8411A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>M16V</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurologic disorder with blindness</td>
<td align="center" colspan="1" rowspan="1" valign="top">1<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">97</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mkaouar-Rebai et al., <xref ref-type="bibr" rid="B78">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8463A&gt;G</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>Y33C</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8472C&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>P36L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">4–8</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8481C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>P39L</td>
<td align="left" colspan="1" rowspan="1" valign="top">ToF</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tansel et al., <xref ref-type="bibr" rid="B127">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8502A&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>N46I</td>
<td align="left" colspan="1" rowspan="1" valign="top">MTLE-HS</td>
<td align="center" colspan="1" rowspan="1" valign="top">40</td>
<td align="center" colspan="1" rowspan="1" valign="top">Adults</td>
<td align="center" colspan="1" rowspan="1" valign="top">11–36</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gurses et al., <xref ref-type="bibr" rid="B38">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8510A&gt;G</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>K49E</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8519G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>E52K</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8528T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>W55R <italic>a</italic>M1T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile cardiomyopathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">5, 3<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.1–4</td>
<td align="center" colspan="1" rowspan="1" valign="top">90–98</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ware et al., <xref ref-type="bibr" rid="B142">2009</xref>; Imai et al., <xref ref-type="bibr" rid="B47">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8529G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>W55X <italic>a</italic>M1I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Apical hypertrophic cardiomyopathy and neuropathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">16</td>
<td align="center" colspan="1" rowspan="1" valign="top">90</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jonckheere et al., <xref ref-type="bibr" rid="B51">2008</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8558C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>P65S <italic>a</italic>A11V</td>
<td align="left" colspan="1" rowspan="1" valign="top">LVHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.2</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tang et al., <xref ref-type="bibr" rid="B125">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8561C&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>8</italic>P66A <italic>a</italic>P12R</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia, neuropathy, diabetes mellitus</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">59, 64</td>
<td align="center" colspan="1" rowspan="1" valign="top">99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kytovuori et al., <xref ref-type="bibr" rid="B65">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8527A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>M1V</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuromuscular Disorder</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Felhi et al., <xref ref-type="bibr" rid="B30">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8597T&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>I24T</td>
<td align="left" colspan="1" rowspan="1" valign="top">MILS</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">95</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsai et al., <xref ref-type="bibr" rid="B131">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8611insC</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L29PfsX36</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ataxia, Encephalopathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">60–80</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jackson et al., <xref ref-type="bibr" rid="B48">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8618insT</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>T33HfsX32</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">40</td>
<td align="center" colspan="1" rowspan="1" valign="top">85</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lopez-Gallardo et al., <xref ref-type="bibr" rid="B70">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8668T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>W48R</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="center" colspan="1" rowspan="1" valign="top">99</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kumar et al., <xref ref-type="bibr" rid="B64">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8684C&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>T53I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism associated Ovarian insufficiency LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 7 1</td>
<td align="center" colspan="1" rowspan="1" valign="top">4–8 25 Adult</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref> Venkatesh et al., <xref ref-type="bibr" rid="B137">2010</xref> Kumar et al., <xref ref-type="bibr" rid="B64">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8697G&gt;A</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>M57I</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism associated LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">4–8</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kumar et al., <xref ref-type="bibr" rid="B64">2010</xref>; Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8701A&gt;G</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>T59A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism associated</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">4–8</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8719G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>G65X</td>
<td align="left" colspan="1" rowspan="1" valign="top">Suspected myopathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;99</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tang et al., <xref ref-type="bibr" rid="B126">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8723G&gt;A</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>R66Q</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8794C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>H90Y</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8836A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>M104V</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON Autism associated</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 3</td>
<td align="center" colspan="1" rowspan="1" valign="top">11 4–8</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abu-Amero and Bosley, <xref ref-type="bibr" rid="B3">2006</xref> Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8839G&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A105P</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">57</td>
<td align="center" colspan="1" rowspan="1" valign="top">21–88</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Blanco-Grau et al., <xref ref-type="bibr" rid="B9">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8843T&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>I106T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref>; Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8851T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>W109R</td>
<td align="left" colspan="1" rowspan="1" valign="top">FBSN</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">87–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Meirleir et al., <xref ref-type="bibr" rid="B23">1995</xref>; Honzik et al., <xref ref-type="bibr" rid="B44">2013</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B59">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8890A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>K122E</td>
<td align="left" colspan="1" rowspan="1" valign="top">MS</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">18</td>
<td align="center" colspan="1" rowspan="1" valign="top">35–38</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ye et al., <xref ref-type="bibr" rid="B146">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8902G&gt;A</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A126T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8932C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>P136S</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuromuscular Disorder</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">7</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Petros et al., <xref ref-type="bibr" rid="B93">2005</xref>; Felhi et al., <xref ref-type="bibr" rid="B30">2016</xref>; Niedzwiecka et al., <xref ref-type="bibr" rid="B85">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8945T&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>M140T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8950G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>V142I</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON plus dystonia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">23</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abu-Amero and Bosley, <xref ref-type="bibr" rid="B2">2005</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8969G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>S148N</td>
<td align="left" colspan="1" rowspan="1" valign="top">MLASA Nephropathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 1</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 14</td>
<td align="center" colspan="1" rowspan="1" valign="top">60–90</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Burrage et al., <xref ref-type="bibr" rid="B13">2014</xref> Wen et al., <xref ref-type="bibr" rid="B144">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>8989G&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A155P</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="center" colspan="1" rowspan="1" valign="top">33–94</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Duno et al., <xref ref-type="bibr" rid="B28">2013</xref>; Wen et al., <xref ref-type="bibr" rid="B144">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8993T&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L156R</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP/MILS</td>
<td align="center" colspan="1" rowspan="1" valign="top">53, 10<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.1–53</td>
<td align="center" colspan="1" rowspan="1" valign="top">13–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Holt et al., <xref ref-type="bibr" rid="B42">1990</xref>; Tatuch et al., <xref ref-type="bibr" rid="B128">1992</xref>; Ciafaloni et al., <xref ref-type="bibr" rid="B19">1993</xref>; Puddu et al., <xref ref-type="bibr" rid="B100">1993</xref>; Trounce et al., <xref ref-type="bibr" rid="B130">1994</xref>; Houstek et al., <xref ref-type="bibr" rid="B45">1995</xref>; Uziel et al., <xref ref-type="bibr" rid="B134">1997</xref>; Vazquez-Memije et al., <xref ref-type="bibr" rid="B136">1998</xref>; Baracca et al., <xref ref-type="bibr" rid="B7">2000</xref>, <xref ref-type="bibr" rid="B8">2007</xref>; Garcia et al., <xref ref-type="bibr" rid="B34">2000</xref>; Nijtmans et al., <xref ref-type="bibr" rid="B86">2001</xref>; Carrozzo et al., <xref ref-type="bibr" rid="B15">2004</xref>; Mattiazzi et al., <xref ref-type="bibr" rid="B75">2004</xref>; Pallotti et al., <xref ref-type="bibr" rid="B89">2004</xref>; Sakai et al., <xref ref-type="bibr" rid="B106">2004</xref>; Enns et al., <xref ref-type="bibr" rid="B29">2006</xref>; Morava et al., <xref ref-type="bibr" rid="B81">2006</xref>; Rojo et al., <xref ref-type="bibr" rid="B104">2006</xref>; Sgarbi et al., <xref ref-type="bibr" rid="B115">2006</xref>; Cortes-Hernandez et al., <xref ref-type="bibr" rid="B20">2007</xref>; Rak et al., <xref ref-type="bibr" rid="B101">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8993T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L156P</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP/MILS</td>
<td align="center" colspan="1" rowspan="1" valign="top">35, 4<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.1–77</td>
<td align="center" colspan="1" rowspan="1" valign="top">20–96</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/Normal</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Vries et al., <xref ref-type="bibr" rid="B24">1993</xref>; Santorelli et al., <xref ref-type="bibr" rid="B108">1994</xref>; Fujii et al., <xref ref-type="bibr" rid="B32">1998</xref>; Vazquez-Memije et al., <xref ref-type="bibr" rid="B136">1998</xref>; Vilarinho et al., <xref ref-type="bibr" rid="B140">2001</xref>; Hurvitz et al., <xref ref-type="bibr" rid="B46">2002</xref>; Pallotti et al., <xref ref-type="bibr" rid="B89">2004</xref>; Morava et al., <xref ref-type="bibr" rid="B81">2006</xref>; Baracca et al., <xref ref-type="bibr" rid="B8">2007</xref>; Craig et al., <xref ref-type="bibr" rid="B21">2007</xref>; Debray et al., <xref ref-type="bibr" rid="B25">2007</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B60">2009a</xref>; Kara et al., <xref ref-type="bibr" rid="B55">2012</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref>; Martikainen et al., <xref ref-type="bibr" rid="B74">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9011C&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A162V</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">34</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shidara and Wakakura, <xref ref-type="bibr" rid="B116">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9016A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>I164V</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">Adult</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Povalko et al., <xref ref-type="bibr" rid="B98">2005</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9025G&gt;A</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>G167S</td>
<td align="left" colspan="1" rowspan="1" valign="top">MILS-like, NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">2, 1<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.2, nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9029A&gt;G</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>H168R</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON-like</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">38</td>
<td align="center" colspan="1" rowspan="1" valign="top">95–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9032T&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L169P</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">16</td>
<td align="center" colspan="1" rowspan="1" valign="top">70–90</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9035T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L170P</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCA</td>
<td align="center" colspan="1" rowspan="1" valign="top">21</td>
<td align="center" colspan="1" rowspan="1" valign="top">4–48</td>
<td align="center" colspan="1" rowspan="1" valign="top">90–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sikorska et al., <xref ref-type="bibr" rid="B117">2009</xref>; Pfeffer et al., <xref ref-type="bibr" rid="B94">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9055G&gt;A</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A177T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9058A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>T178A</td>
<td align="left" colspan="1" rowspan="1" valign="top">LVHT</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tang et al., <xref ref-type="bibr" rid="B125">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9071C&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>S182L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9094C&gt;T</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L190F</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ovarian insufficiency</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">25</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Venkatesh et al., <xref ref-type="bibr" rid="B137">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9101T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>I192T</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">21</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lamminen et al., <xref ref-type="bibr" rid="B67">1995</xref>; Majander et al., <xref ref-type="bibr" rid="B72">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9127delAT</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>I201PfsX2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NARP</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">18</td>
<td align="center" colspan="1" rowspan="1" valign="top">10–82</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mordel et al., <xref ref-type="bibr" rid="B82">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9134A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>E203G</td>
<td align="left" colspan="1" rowspan="1" valign="top">MS with cardiomyopathy</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Honzik et al., <xref ref-type="bibr" rid="B43">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9139G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>A205T</td>
<td align="left" colspan="1" rowspan="1" valign="top">LHON</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">30,45</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">La Morgia et al., <xref ref-type="bibr" rid="B66">2008</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>9160T&gt;C</underline>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>Y212H</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td align="center" colspan="1" rowspan="1" valign="top">nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">U</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9176T&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L217R</td>
<td align="left" colspan="1" rowspan="1" valign="top">MILS</td>
<td align="center" colspan="1" rowspan="1" valign="top">6, 3<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">3–42</td>
<td align="center" colspan="1" rowspan="1" valign="top">95–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thyagarajan et al., <xref ref-type="bibr" rid="B129">1995</xref>; Dionisi-Vici et al., <xref ref-type="bibr" rid="B27">1998</xref>; Makino et al., <xref ref-type="bibr" rid="B73">1998</xref>; Okamoto et al., <xref ref-type="bibr" rid="B87">1998</xref>; Jacobs et al., <xref ref-type="bibr" rid="B49">2005</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B61">2009b</xref>; Ronchi et al., <xref ref-type="bibr" rid="B105">2011</xref>; Verny et al., <xref ref-type="bibr" rid="B138">2011</xref>; Synofzik et al., <xref ref-type="bibr" rid="B124">2012</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9176T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L217P</td>
<td align="left" colspan="1" rowspan="1" valign="top">MILS, Periodic paralyzes, CMT, HSP</td>
<td align="center" colspan="1" rowspan="1" valign="top">19, 4<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">1–59</td>
<td align="center" colspan="1" rowspan="1" valign="top">90–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thyagarajan et al., <xref ref-type="bibr" rid="B129">1995</xref>; Dionisi-Vici et al., <xref ref-type="bibr" rid="B27">1998</xref>; Makino et al., <xref ref-type="bibr" rid="B73">1998</xref>; Okamoto et al., <xref ref-type="bibr" rid="B87">1998</xref>; Jacobs et al., <xref ref-type="bibr" rid="B49">2005</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B58">2010</xref>; Ronchi et al., <xref ref-type="bibr" rid="B105">2011</xref>; Verny et al., <xref ref-type="bibr" rid="B138">2011</xref>; Synofzik et al., <xref ref-type="bibr" rid="B124">2012</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9185T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L220P</td>
<td align="left" colspan="1" rowspan="1" valign="top">Periodic paralyzes, Ataxia, MILS, CMT, MNS, SCA</td>
<td align="center" colspan="1" rowspan="1" valign="top">61, 4<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">2–58</td>
<td align="center" colspan="1" rowspan="1" valign="top">73–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moslemi et al., <xref ref-type="bibr" rid="B83">2005</xref>; Castagna et al., <xref ref-type="bibr" rid="B16">2007</xref>; Childs et al., <xref ref-type="bibr" rid="B17">2007</xref>; Saneto and Singh, <xref ref-type="bibr" rid="B107">2010</xref>; Pfeffer et al., <xref ref-type="bibr" rid="B94">2012</xref>; Pitceathly et al., <xref ref-type="bibr" rid="B96">2012</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref>; Brum et al., <xref ref-type="bibr" rid="B12">2014</xref>; Kabala et al., <xref ref-type="bibr" rid="B54">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9191T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>L222P</td>
<td align="left" colspan="1" rowspan="1" valign="top">MILS</td>
<td align="center" colspan="1" rowspan="1" valign="top">1<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
<td align="center" colspan="1" rowspan="1" valign="top">90–94</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moslemi et al., <xref ref-type="bibr" rid="B83">2005</xref>; Kabala et al., <xref ref-type="bibr" rid="B54">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9205delTA</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>a</italic>STOP elimination</td>
<td align="left" colspan="1" rowspan="1" valign="top">Encephalopathy/Lactic acidosis</td>
<td align="center" colspan="1" rowspan="1" valign="top">3, 1<xref ref-type="table-fn" rid="TN1"><sup>†</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">Adult, nd</td>
<td align="center" colspan="1" rowspan="1" valign="top">98–99</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd</td>
<td align="left" colspan="1" rowspan="1" valign="top">nd/Abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Seneca et al., <xref ref-type="bibr" rid="B113">1996</xref>; Jesina et al., <xref ref-type="bibr" rid="B50">2004</xref>; Hejzlarova et al., <xref ref-type="bibr" rid="B40">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">C</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>†</label>
<p><italic>–nr of died patients, nd, no data; PG, pathogenicity; C, confirmed; S, suspected; U, unknown; mutations not present in the MITOMAP list are underlined</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec>
<title>Mutations affecting only subunit <italic>8</italic></title>
<p>Ten mutations affecting only subunit <italic>8</italic> were identified in patients presenting with various disorders: epilepsy [<bold>m.8502A</bold>&gt;<bold>T</bold> (<italic>8</italic>N46I)] (Gurses et al., <xref ref-type="bibr" rid="B38">2014</xref>); LVHT or MIDD <bold>[m.8381A</bold>&gt;<bold>G</bold> (<italic>8</italic>T6A)] (Perucca-Lostanlen et al., <xref ref-type="bibr" rid="B92">2000</xref>; Finsterer et al., <xref ref-type="bibr" rid="B31">2004</xref>); brain pseudo-atrophy, episodic weakness and neurological disorders [<bold>m.8393C</bold>&gt;<bold>T</bold> (<italic>8</italic>P10S) (Galimberti et al., <xref ref-type="bibr" rid="B33">2006</xref>), <bold>m.8403T</bold>&gt;<bold>C</bold> (<italic>8</italic>I13T) (Aure et al., <xref ref-type="bibr" rid="B5">2013</xref>), and <bold>m.8411A</bold>&gt;<bold>G</bold> (<italic>8</italic>M16V) (Mkaouar-Rebai et al., <xref ref-type="bibr" rid="B78">2010</xref>)], heart problems [<bold>m.8481C</bold>&gt;<bold>T</bold> (<italic>8</italic>P39L)] (Tansel et al., <xref ref-type="bibr" rid="B127">2014</xref>); schizophrenia [<bold>m.8463A</bold>&gt;<bold>G</bold> (<italic>8</italic>Y33C)<bold>, m.8510A</bold>&gt;<bold>G</bold> (<italic>8</italic>K49E) and <bold>m.8519G</bold>&gt;<bold>A</bold> (<italic>8</italic>E52K)] (Ueno et al., <xref ref-type="bibr" rid="B133">2009</xref>; Sequeira et al., <xref ref-type="bibr" rid="B114">2015</xref>); and autism [<bold>m.8472C</bold>&gt;<bold>T</bold> (<italic>8</italic>P36L)] (Piryaei et al., <xref ref-type="bibr" rid="B95">2012</xref>).</p>
</sec>
<sec>
<title>Mutations affecting both subunits <italic>8</italic> and <italic>a</italic></title>
<p>Three mutations affecting both subunits <italic>8</italic> and <italic>a</italic> [<bold>m.8528T</bold>&gt;<bold>C</bold> (<italic>8</italic>W55R + <italic>a</italic>M1T), <bold>m.8529G</bold>&gt;<bold>A</bold> (<italic>8</italic>W55STOP + <italic>a</italic>M1I), <bold>m.8558C</bold>&gt;<bold>T</bold> (<italic>8</italic>P65S + <italic>a</italic>A11V)] were identified in patients suffering from severe cardiomyopathies (Jonckheere et al., <xref ref-type="bibr" rid="B51">2008</xref>; Ware et al., <xref ref-type="bibr" rid="B142">2009</xref>; Tang et al., <xref ref-type="bibr" rid="B125">2010</xref>; Imai et al., <xref ref-type="bibr" rid="B47">2016</xref>). A fourth mutation affecting both proteins [<bold>m.8561C</bold>&gt;<bold>G</bold> (<italic>8</italic>P66A + <italic>a</italic>P12R)] was detected in individuals with features of cerebellar ataxia, peripheral neuropathy and diabetes mellitus (Kytovuori et al., <xref ref-type="bibr" rid="B65">2016</xref>).</p>
</sec>
<sec>
<title>Mutations affecting only subunit <italic>a</italic></title>
<sec>
<title>Most frequent mutations</title>
<list list-type="bullet">
<list-item>
<p>Two mutations at the same amino acid position of subunit <italic>a</italic>, <bold>m.8993T</bold>&gt;<bold>G</bold> (<italic>a</italic>L156R) and <bold>m.8993T</bold>&gt;<bold>C</bold> (<italic>a</italic>L156P), were identified in numerous patients presenting with the NARP or MILS syndrome depending on the mutation load (Uziel et al., <xref ref-type="bibr" rid="B134">1997</xref>; Jonckheere et al., <xref ref-type="bibr" rid="B52">2012</xref>). The first one was consistently found to severely compromise mitochondrial ATP production, with deficits of up to 90%. While most studies concluded this was due to a block in proton translocation, some suggested a less efficient coupling or defects in the assembly/stability of ATP synthase (Tatuch et al., <xref ref-type="bibr" rid="B128">1992</xref>; Trounce et al., <xref ref-type="bibr" rid="B130">1994</xref>; Houstek et al., <xref ref-type="bibr" rid="B45">1995</xref>; Vazquez-Memije et al., <xref ref-type="bibr" rid="B136">1998</xref>; Garcia et al., <xref ref-type="bibr" rid="B34">2000</xref>; Nijtmans et al., <xref ref-type="bibr" rid="B86">2001</xref>; Carrozzo et al., <xref ref-type="bibr" rid="B15">2004</xref>; Mattiazzi et al., <xref ref-type="bibr" rid="B75">2004</xref>; Pallotti et al., <xref ref-type="bibr" rid="B89">2004</xref>; Morava et al., <xref ref-type="bibr" rid="B81">2006</xref>; Sgarbi et al., <xref ref-type="bibr" rid="B115">2006</xref>; Baracca et al., <xref ref-type="bibr" rid="B8">2007</xref>; Cortes-Hernandez et al., <xref ref-type="bibr" rid="B20">2007</xref>). Although its pathogenic character is firmly established, the second mutation has less severe consequences on ATP synthase with a 70% drop in ATP production mainly because of a less efficient assembly or diminished stability of subunit <italic>a</italic> (Vilarinho et al., <xref ref-type="bibr" rid="B140">2001</xref>; Morava et al., <xref ref-type="bibr" rid="B81">2006</xref>; Craig et al., <xref ref-type="bibr" rid="B21">2007</xref>; Kucharczyk et al., <xref ref-type="bibr" rid="B60">2009a</xref>; Aure et al., <xref ref-type="bibr" rid="B5">2013</xref>). In addition to bioenergetic deficits, the two mutations lead to an enhanced production of ROS and aberrant mitochondrial morphologies that may contribute to the disease process as well.</p>
</list-item>
<list-item>
<p>Similar diseases were associated with two mutations at amino acid position 217, <bold>m.9176T</bold>&gt;<bold>G</bold> (<italic>a</italic>L217R), and <bold>m.9176T</bold>&gt;<bold>C</bold> (<italic>a</italic>L217P). The first one is extremely detrimental with a block in subunit <italic>a</italic> assembly that leads to extreme clinical phenotypes when highly abundant in cells and tissues. The second one does not obviously compromise assembly of subunit <italic>a</italic> indicating that it affects the functioning of ATP synthase.</p>
</list-item>
<list-item>
<p>The <bold>m.9185T</bold>&gt;<bold>C</bold> (<italic>a</italic>L220P) mutation was identified in individuals presenting with MILS, MNS, periodic paralyzes, spinocerebellar ataxia syndromes (SCA) or CMT (Castagna et al., <xref ref-type="bibr" rid="B16">2007</xref>; Childs et al., <xref ref-type="bibr" rid="B17">2007</xref>). Biochemical analyses revealed a substantial drop (50–90%) in ATP production, and study in yeast indicated that this mutation compromises the functioning of ATP synthase (Kabala et al., <xref ref-type="bibr" rid="B54">2014</xref>).</p>
</list-item>
</list>
</sec>
<sec>
<title>Other, less frequent, mutations in subunit <italic>a</italic></title>
<list list-type="bullet">
<list-item>
<p>Eight additional mutations in subunit <italic>a</italic> [<bold>m.8597T</bold>&gt;<bold>C</bold> (<italic>a</italic>I24T), <bold>m.8618insT</bold>, <bold>m.8839G</bold>&gt;<bold>C</bold> (<italic>a</italic>A105P), <bold>m.8989G</bold>&gt;<bold>C</bold> (<italic>a</italic>A155P), <bold>m.9025G</bold>&gt;<bold>A</bold> (<italic>a</italic>G167S), <bold>m.9032T</bold>&gt;<bold>C</bold> (<italic>a</italic>L169P), <bold>m.9127delAT</bold> (<italic>a</italic>I201PfsX2) and <bold>m.9191T</bold>&gt;<bold>C</bold> (<italic>a</italic>L222P)] were identified in patients presenting with NARP or MILS disease. Although they were thus far found only in a limited number of individuals, biochemical investigations indicated that they have detrimental consequences for ATP synthase. For instance, the <bold>m.9191T</bold>&gt;<bold>C</bold> was shown to dramatically affect incorporation of subunit <italic>a</italic> in the yeast enzyme (Kabala et al., <xref ref-type="bibr" rid="B54">2014</xref>). These mutations are thus most likely pathogenic.</p>
</list-item>
<list-item>
<p>The <bold>m.8969G</bold>&gt;<bold>A</bold> (<italic>a</italic>S148N) mutation was found in a patient presenting with MLASA (Burrage et al., <xref ref-type="bibr" rid="B13">2014</xref>) and a 14-year-old Chinese girl diagnosed with a severe nephropathy (Wen et al., <xref ref-type="bibr" rid="B144">2016</xref>). Biochemical investigations in yeast and human cells revealed a block in the transfer of protons through the F<sub>o</sub>.</p>
</list-item>
<list-item>
<p>The <bold>m.8851T</bold>&gt;<bold>C</bold> (<italic>a</italic>W109R) and <bold>m.8890A</bold>&gt;<bold>G</bold> (<italic>a</italic>K122E) mutations were identified in patients presenting with FBSN and MS (De Meirleir et al., <xref ref-type="bibr" rid="B23">1995</xref>; Honzik et al., <xref ref-type="bibr" rid="B44">2013</xref>; Ye et al., <xref ref-type="bibr" rid="B146">2013</xref>). Studies with yeast revealed that <bold>m.8851T</bold>&gt;<bold>C</bold> leads to major drops (95%) in mitochondrial ATP synthesis owing to a block in F<sub>o</sub>-mediated proton transfer (Kucharczyk et al., <xref ref-type="bibr" rid="B59">2013</xref>). The <bold>m.9134A</bold>&gt;<bold>G</bold> (<italic>a</italic>E203G) was identified in patient suffering from MS accompanied with cardiomyopathy (Honzik et al., <xref ref-type="bibr" rid="B43">2012</xref>).</p>
</list-item>
<list-item>
<p>The <bold>m.9035T</bold>&gt;<bold>C</bold> (<italic>a</italic>L170P) was identified at high (&gt;90%) mutation load in 21 ataxia patients (Sikorska et al., <xref ref-type="bibr" rid="B117">2009</xref>; Pfeffer et al., <xref ref-type="bibr" rid="B94">2012</xref>). Cybrids carrying this mutation had reduced ATP levels (40–50% vs. controls) and produced 5–7 times more ROS than control cells. Another mutation <bold>m.8611insC</bold> (<italic>a</italic>L29PfsX36) was found in patient presenting ataxia with encephalomyopathy (Jackson et al., <xref ref-type="bibr" rid="B48">2017</xref>).</p>
</list-item>
<list-item>
<p>Ten mutations [<bold>m.8668T</bold>&gt;<bold>C</bold> (<italic>a</italic>W48R), <bold>m.8684C</bold>&gt;<bold>T</bold> (<italic>a</italic>T53I), <bold>m.8697G</bold>&gt;<bold>A</bold> (<italic>a</italic>M57I), <bold>m.8836A</bold>&gt;<bold>G</bold> (<italic>a</italic>M104V), <bold>m.8950G</bold>&gt;<bold>A</bold> (<italic>a</italic>V142I), <bold>m.9011C</bold>&gt;<bold>T</bold> (<italic>a</italic>A162V), <bold>m.9016A</bold>&gt;<bold>G</bold> (<italic>a</italic>I164V), <bold>m.9029A</bold>&gt;<bold>G</bold> (<italic>a</italic>H168R), <bold>m.9101T</bold>&gt;<bold>C</bold> (<italic>a</italic>I192T), and <bold>m.9139G</bold>&gt;<bold>A</bold> (<italic>a</italic>A205T)] were identified in patients presenting with LHON, a disease caused by defects in the retinal ganglion cells and optic nerve that lead to blindness. Two of them (<bold>m.9029A</bold>&gt;<bold>G</bold> and <bold>m.9101T</bold>&gt;<bold>C</bold>) were shown to compromise oxidative phosphorylation by a yet-unknown mechanism (Lamminen et al., <xref ref-type="bibr" rid="B67">1995</xref>; Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref>).</p>
</list-item>
<list-item>
<p>The <bold>m.8932C</bold>&gt;<bold>T</bold> (<italic>a</italic>P136S) and <bold>m.8527A</bold>&gt;<bold>G</bold> (<italic>a</italic>M1V) were identified in children with neuromuscular disorders (Felhi et al., <xref ref-type="bibr" rid="B30">2016</xref>). The first one was also identified in prostatic cancer cells (Petros et al., <xref ref-type="bibr" rid="B93">2005</xref>). In a yeast model of this mutation, ATP synthase assembly/stability was found substantially affected (Niedzwiecka et al., <xref ref-type="bibr" rid="B85">2016</xref>).</p>
</list-item>
<list-item>
<p>The <bold>m.9205delTA</bold> (<italic>a</italic>STOP elimination) mutation was identified in patients with a severe encephalopathy leading to premature death. Since the stop codon of ATP6 overlaps with the start codon of COX3, the expression of both genes is compromised, which results in a lower content in complex IV and ATP synthase (Jesina et al., <xref ref-type="bibr" rid="B50">2004</xref>; Hejzlarova et al., <xref ref-type="bibr" rid="B40">2015</xref>).</p>
</list-item>
<list-item>
<p>The <bold>m.8719G</bold>&gt;<bold>A</bold> (<italic>a</italic>G65STOP) and <bold>m.9058A</bold>&gt;<bold>G</bold> (<italic>a</italic>T178A) mutations were identified in patients presenting with LVHT (Tang et al., <xref ref-type="bibr" rid="B125">2010</xref>, <xref ref-type="bibr" rid="B126">2013</xref>). Their biochemical consequences are still unknown.</p>
</list-item>
<list-item>
<p>Ten mutations [<bold>m.8701A</bold>&gt;<bold>G</bold> (<italic>a</italic>T59A), <bold>m.8723G</bold>&gt;<bold>A</bold> (<italic>a</italic>R66Q), <bold>m.8794C</bold>&gt;<bold>T</bold> (<italic>a</italic>H90Y), <bold>m.8843T</bold>&gt;<bold>C</bold> (<italic>a</italic>I106T), <bold>m.8902G</bold>&gt;<bold>A</bold> (<italic>a</italic>A126T), <bold>m.8945T</bold>&gt;<bold>C</bold> (<italic>a</italic>M140T), <bold>m.9055G</bold>&gt;<bold>A</bold> (<italic>a</italic>I177T), <bold>m.9071C</bold>&gt;<bold>T</bold> (<italic>a</italic>S182L), <bold>m.9094C</bold>&gt;<bold>T</bold> (<italic>a</italic>L190F), and <bold>m.9160T</bold>&gt;<bold>C</bold> (<italic>a</italic>Y212H)] were found in patients with autism or schizophrenia. Their consequences on ATP synthase has not yet been investigated.</p>
</list-item>
</list>
<p>It is puzzling that mutations that cluster in specific regions of ATP6 or ATP8 give rise to such a wide variety of clinical symptoms (Table <xref ref-type="table" rid="T1">1</xref>). These phenotypic differences may be due to other unknown genetic variations in patients within mitochondrial or nuclear DNA that could exacerbate or attenuate the consequences on health of defects in ATP synthase subunits. Another important source of variability in the clinical outcome likely resides in the levels of heteroplasmy and different distributions of mtDNA mutations in cells and tissues. Furthermore, in addition to a lack of ATP, defects in ATP synthase may have multiple secondary effects, such as increased production of ROS and changes in upstream metabolic processes (Korshunov et al., <xref ref-type="bibr" rid="B57">1997</xref>) that together will influence the disease process unpredictably.</p>
</sec>
</sec>
</sec>
<sec id="s5">
<title>Topology within the F<sub>o</sub> of mutations in subunits <italic>a</italic> and <italic>8</italic></title>
<p>To define the topology of the ATP6 and ATP8 mutations identified in patients, we used the recently published structures of <italic>Y. lipolytica</italic> and <italic>S. cerevisiae</italic> ATP synthases (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>); the complete model of subunits <italic>a, 8</italic>, and the <italic>c</italic>-ring is shown in Figure <xref ref-type="fig" rid="F4">4</xref>. The amino acid alignments in Figure <xref ref-type="fig" rid="F3">3</xref> establish the correspondences with human subunits <italic>a</italic> and <italic>8</italic> amino acids.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Positions of human neurodegenerative disease-causing mutations in the structure of the yeast mitochondrial ATP synthase subunits <italic>a</italic> and <italic>8</italic> (human <italic>A6L</italic>). The views are from the matrix <bold>(A,B)</bold> and from the IMS <bold>(C,D)</bold> with detailed views in the IMS entry channel <bold>(B)</bold> and in the matrix exit channel <bold>(D)</bold>. On <bold>(E,F)</bold>, showing views along the membrane plane from outside the F<sub>o</sub> stator and from the <italic>c</italic>-ring, respectively, the membrane borders are indicated as black lines. Subunits <italic>a, 8</italic>, and <italic>c</italic> are shown in blue, green, and yellow, respectively. The model is based on structural data from the <italic>Y. lipolytica</italic> and <italic>S. cerevisiae</italic> structures (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). The positions of mutations, which have been found in human neurodegenerative diseases, are marked in white, red, blue, pink, orange and black for hydrophobic, negatively and positively charged, uncharged polar, proline and special residues, respectively. The mutations are labeled according to their positions in human subunit <italic>a</italic> listed in Table <xref ref-type="table" rid="T2">2</xref>. The arrows indicate the path of protons in ATP synthesis direction. The conserved arginine (<italic>h.s. a</italic>R159, <italic>S.c. a</italic>R186) on helix <italic>a</italic>H5 is indicated by stick model; its orientation is randomly chosen. The figure was drawn with UCSF ChimeraX (Goddard et al., <xref ref-type="bibr" rid="B35">2017</xref>).</p>
</caption>
<graphic xlink:href="fphys-09-00329-g0004"></graphic>
</fig>
<sec>
<title>Subunit <italic>a</italic> mutations</title>
<p>Helix 5 of subunit <italic>a</italic> (<italic>a</italic>H5) is kinked due to the presence of proline at position 153, a residue well-known for its propensity to bend or break alpha helices owing to its inability to participate fully in protein backbone hydrogen bonding. <italic>a</italic>P153 enables <italic>a</italic>H5 to follow the curvature of the <italic>c</italic>-ring and seal the two hydrophilic pockets that connect the <italic>a</italic>/c-ring interface to the intermembrane and matrix spaces. Five substitutions from hydrophobic alanine or leucine residues into proline are located on <italic>a</italic>H5 (<italic>a</italic>H5) in proximity to the essential <italic>a</italic>R159 residue (<italic>a</italic>A105P, <italic>a</italic>A155P and <italic>a</italic>L156P) that faces the proton binding glutamate of the <italic>c</italic>-ring, or close to <italic>a</italic>H168/<italic>a</italic>E203 in the proton entry channel (<italic>a</italic>L169P, <italic>a</italic>L170P). These mutations may distort or break <italic>a</italic>H5. Those at positions 155 and 156 at one helix turn from <italic>a</italic>R159 may compromise the ion translocation mechanism, for example by ion short circuiting (Mitome et al., <xref ref-type="bibr" rid="B77">2010</xref>) or by preventing <italic>a</italic>R159 to interact with the <italic>c</italic>-ring glutamate due to its structurally shifted position. On <italic>a</italic>H6, the <italic>a</italic>L217P, <italic>a</italic>L220P, and <italic>a</italic>L222P mutations are on the edge of the exit channel close to the matrix. Their severe functional consequences possibly result from a change in the topology of the nearby <italic>a</italic>D224 residue that was suggested to be of critical importance for the exit of protons toward the mitochondrial matrix (Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). Similarly, the <italic>a</italic>P136S change in the loop connecting <italic>a</italic>H4 and <italic>a</italic>H5 possibly alters the accessibility of protons in this region of subunit <italic>a</italic>.</p>
<p>The extremely detrimental consequences of <italic>a</italic>L217R on ATP synthase assembly/stability (Kucharczyk et al., <xref ref-type="bibr" rid="B61">2009b</xref>) possibly results from the inability of subunit <italic>a</italic> to pack tightly owing to replacement of a hydrophobic residue with a bulkier and positively charged one within the membrane. The absence of proton conduction induced by the <italic>a</italic>L156R mutation at the <italic>a</italic>/<italic>c</italic>-ring interface (Rak et al., <xref ref-type="bibr" rid="B101">2007</xref>), without any defect in ATP synthase assembly, may be caused by the inability of protons to exit from the ring or by electrostatic or steric hindrance that prevent rotation of the ring. Being located near the N-terminal side of <italic>a</italic>H5, the block in proton translocation induced by the <italic>a</italic>S148N mutation (Wen et al., <xref ref-type="bibr" rid="B144">2016</xref>) possibly results from obstruction of the proton exit pore. The detrimental consequences of <italic>a</italic>H168R (Lopez-Gallardo et al., <xref ref-type="bibr" rid="B69">2014</xref>) are not surprising considering its location in the <italic>p</italic>-side cleft in the proximity of the <italic>c</italic>-ring. This positive charge cuts off the connection of the <italic>p</italic>-side to the <italic>c</italic>-ring. A similar effect on the <italic>n</italic>-side of the membrane may result from the <italic>a</italic>W109R, where <italic>a</italic>H5 and <italic>a</italic>H6 diverge. A mutation at this position has an impact in proton translocation without impacting ATP synthase assembly/stability (Kucharczyk et al., <xref ref-type="bibr" rid="B59">2013</xref>), indicating that this location of subunit <italic>a</italic> is close to the pathway along which protons are evacuated into the matrix. The clinical consequences of <italic>a</italic>K122E probably also result from a less efficient proton conduction toward the matrix.</p>
<p>While <italic>a</italic>M140T, <italic>a</italic>G167S, <italic>a</italic>A177T, <italic>a</italic>I192T, <italic>a</italic>A205T, and <italic>a</italic>Y212H decrease the hydrophobicity of the <italic>a</italic>/<italic>c</italic>-ring interface, it is less obvious from our structural model to predict the consequences of other mutations that replace hydrophobic to non-charged hydrophilic residues (<italic>a</italic>I24T, <italic>a</italic>I106T, <italic>a</italic>A126T) or vice-versa (<italic>a</italic>T53I, <italic>a</italic>T59A, <italic>a</italic>T178A, <italic>a</italic>S182L) and those that lead to small hydrophobicity changes (<italic>a</italic>M57I, <italic>a</italic>M104V, <italic>a</italic>V142I, <italic>a</italic>A162V, <italic>a</italic>I164V, <italic>a</italic>L190F). However, meaningfully, most are within helices <italic>a</italic>H4-6 that are important for the movement of protons through F<sub>o</sub>.</p>
</sec>
<sec>
<title>Subunit <italic>8</italic> mutations</title>
<p>The yeast subunit <italic>8</italic> has an overall kinked helical structure with a N-terminal transmembrane helix (<italic>8</italic>H1) and a short helix (<italic>8</italic>H2) exposed to the matrix. <italic>8</italic>H1 is flanked by subunit <italic>i</italic> and <italic>a</italic>H1 (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>). At the distal stator side, <italic>8</italic>H1 is exposed toward the dimer interface in a bent lipid bilayer region. At the base of the peripheral stalk, the C-terminus of <italic>8</italic>H2 is nestled inside the helical domain composed by subunits <italic>b, d</italic> and <italic>f</italic>. In vertebrates, no secondary structures are predicted in the C-terminal half of subunit <italic>8</italic> and subunit <italic>f</italic> displays only 18% identity with its yeast homolog, which explains why they could not be modeled from the bovine ATP synthase cryo-EM density map (Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>). Subunit <italic>8</italic> shows at its N-terminus a conserved 4 amino acid motif (MPQL, Figure <xref ref-type="fig" rid="F3">3</xref>). This motif and <italic>8</italic>H1 share significant homologies with one of the two subunits <italic>b</italic> (isoform <italic>b</italic>′ or <italic>b2</italic>) from α-proteobacteria (Figure <xref ref-type="fig" rid="F3">3A</xref>), indicating that subunit <italic>8</italic> (<italic>A6L</italic>) is an evolutionary vestige of bacterial subunit <italic>b</italic> that remained mtDNA encoded (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>). Subunit <italic>8</italic> stabilizes in the membrane the helical N-terminal half of subunit <italic>a</italic> (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>). Four of the mutations identified in patients (<italic>8</italic>T6A, <italic>8</italic>P10S, <italic>8</italic>I13T, <italic>8</italic>M16V) cluster at the N-terminal region of helix <italic>8</italic>H1 in proximity to <italic>a</italic>H4, suggesting that they may affect the stability of subunits <italic>a</italic> and <italic>8</italic> (Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>). The six other mutations identified in patients (<italic>8</italic>Y33C, <italic>8</italic>P36L, <italic>8</italic>P39L, <italic>8</italic>N46I, <italic>8</italic>K49E, <italic>8</italic>E52K) are in the matrix-exposed helix <italic>8</italic>H2. These mutations might affect the flexibility of the outer stalk, and thereby compromise the stability of F<sub>o</sub> and/or, indirectly, the ion translocation mechanism or ATP synthase assembly process. This hypothesis is supported by the reduced functionality and stability of ATP synthase in these patients and by various studies on subunit <italic>b</italic> in the bacterial enzyme (Schneider and Altendorf, <xref ref-type="bibr" rid="B111">1984</xref>, <xref ref-type="bibr" rid="B112">1985</xref>; Wehrle et al., <xref ref-type="bibr" rid="B143">2002</xref>; Greie et al., <xref ref-type="bibr" rid="B36">2004</xref>).</p>
</sec>
</sec>
<sec id="s6">
<title>ATP synthase dimers and mitochondrial morphology</title>
<p>The mitochondrial ATP synthase exists as dimers (Schagger and Pfeiffer, <xref ref-type="bibr" rid="B110">2000</xref>; Paumard et al., <xref ref-type="bibr" rid="B91">2002</xref>) that associate into rows that contribute to cristae formation (Davies et al., <xref ref-type="bibr" rid="B22">2011</xref>; Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>). The mutations in subunits <italic>8</italic> and <italic>a</italic> often correlate with pathological forms of mitochondria cristae as for example seen in the Leigh syndrome (Kucharczyk et al., <xref ref-type="bibr" rid="B61">2009b</xref>). The defects caused by these mutations therefore not only affect the ATP synthase function but they can also affect the assembly process. The reduced amount, or lack thereof, of native and completely assembled ATP synthase dimers would certainly affect cristae formation, which is crucial for the accommodation of the OXPHOS respiratory chain complexes and the ATP synthase. This explains some of the pathologic forms of mitochondria found in the diseases and syndromes described in this review.</p>
</sec>
<sec id="s7" sec-type="conclusions">
<title>Conclusions</title>
<p>Diseases associated to mutations in the mitochondrial ATP6 and ATP8 genes are particularly challenging to study due to factors like heteroplasmy, complex inheritance, variable penetrance, and interactions with (e.g., nuclear) modifier genes, which makes it difficult to verify their pathogenicity. The possibility to create and keep alive homoplasmic strains of <italic>S. cerevisiae</italic> with defined mtDNA mutations in a controlled nuclear genetic background makes it possible to study their functional consequences. With the recently obtained cryo-EM structures of F<sub>1</sub>F<sub>o</sub> ATP synthase from various mitochondrial origins it has become feasible to map mutations in ATP6 and ATP8 at the molecular level within the F<sub>o</sub>. These “open eyes” provide the chance for a completely new level of understanding of how the mutations may affect ATP synthase structure, assembly, and mechanism. This knowledge also enables to evaluate the observed pathogenic forms of mitochondrial morphology that are associated with these syndromes on the structural level, from the mutation at the molecular level to its associated consequences at the macroscopic scale of the organelle. The recent technical advances enabling the structural analysis of macromolecular complexes by cryo-EM (Kühlbrandt, <xref ref-type="bibr" rid="B63">2014</xref>), the advent of complete structures of ATP synthases (Allegretti et al., <xref ref-type="bibr" rid="B4">2015</xref>; Morales-Rios et al., <xref ref-type="bibr" rid="B80">2015b</xref>; Zhou et al., <xref ref-type="bibr" rid="B148">2015</xref>; Hahn et al., <xref ref-type="bibr" rid="B39">2016</xref>; Sobti et al., <xref ref-type="bibr" rid="B119">2016</xref>; Guo et al., <xref ref-type="bibr" rid="B37">2017</xref>) and the availability of genetically approachable systems like <italic>S. cerevisiae</italic> are just the first steps in these new shoes; they will considerably improve the comprehension of human diseases associated to defects in this key mitochondrial enzyme. We are still at the beginning of understanding these complex processes.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>AD, AH, TM, DT-T, J-PdR, and RK discussed findings, analyzed literature and wrote the manuscript; AD, AH, and TM designed and made the Figures.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>This work was funded by grants from Association Française contre les Myopathies to J-PdR., the Agence Nationale de la Recherche (ANR-12-BSV8-024) to AD, the National Science Center of Poland (UMO-2016/23/B/NZ3/02098) to RK and by the Wellcome Trust to TM (WT110068/Z/15/Z).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrahams</surname><given-names>J. P.</given-names></name><name><surname>Leslie</surname><given-names>A. G.</given-names></name><name><surname>Lutter</surname><given-names>R.</given-names></name><name><surname>Walker</surname><given-names>J. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Structure at 2.8 Å resolution of F<sub>1</sub>-ATPase from bovine heart mitochondria</article-title>. <source/>Nature
<volume>370</volume>, <fpage>621</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/370621a0</pub-id><pub-id pub-id-type="pmid">8065448</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Amero</surname><given-names>K. K.</given-names></name><name><surname>Bosley</surname><given-names>T. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin</article-title>. <source/>Arch. Pathol. Lab. Med.
<volume>129</volume>, <fpage>1295</fpage>–<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1043/1543-2165(2005)129[1295:DOMRDI]2.0.CO;2</pub-id><pub-id pub-id-type="pmid">16196519</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Amero</surname><given-names>K. K.</given-names></name><name><surname>Bosley</surname><given-names>T. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial abnormalities in patients with LHON-like optic neuropathies</article-title>. <source/>Invest. Ophthalmol. Vis. Sci.
<volume>47</volume>, <fpage>4211</fpage>–<lpage>4220</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.06-0295</pub-id><pub-id pub-id-type="pmid">17003408</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allegretti</surname><given-names>M.</given-names></name><name><surname>Klusch</surname><given-names>N.</given-names></name><name><surname>Mills</surname><given-names>D. J.</given-names></name><name><surname>Vonck</surname><given-names>J.</given-names></name><name><surname>Kühlbrandt</surname><given-names>W.</given-names></name><name><surname>Davies</surname><given-names>K. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Horizontal membrane-intrinsic α-helices in the stator a-subunit of an F-type ATP synthase</article-title>. <source/>Nature
<volume>521</volume>, <fpage>237</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nature14185</pub-id><pub-id pub-id-type="pmid">25707805</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auré</surname><given-names>K.</given-names></name><name><surname>Dubourg</surname><given-names>O.</given-names></name><name><surname>Jardel</surname><given-names>C.</given-names></name><name><surname>Clarysse</surname><given-names>L.</given-names></name><name><surname>Sternberg</surname><given-names>D.</given-names></name><name><surname>Fournier</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Episodic weakness due to mitochondrial DNA MT-ATP6/8 mutations</article-title>. <source/>Neurology
<volume>81</volume>, <fpage>1810</fpage>–<lpage>1818</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000436067.43384.0b</pub-id><pub-id pub-id-type="pmid">24153443</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baile</surname><given-names>M. G.</given-names></name><name><surname>Claypool</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>The power of yeast to model diseases of the powerhouse of the cell</article-title>. <source/>Front. Biosci.
<volume>18</volume>, <fpage>241</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.2741/4098</pub-id><pub-id pub-id-type="pmid">23276920</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baracca</surname><given-names>A.</given-names></name><name><surname>Barogi</surname><given-names>S.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Lenaz</surname><given-names>G.</given-names></name><name><surname>Solaini</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>4177</fpage>–<lpage>4182</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.6.4177</pub-id><pub-id pub-id-type="pmid">10660580</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baracca</surname><given-names>A.</given-names></name><name><surname>Sgarbi</surname><given-names>G.</given-names></name><name><surname>Mattiazzi</surname><given-names>M.</given-names></name><name><surname>Casalena</surname><given-names>G.</given-names></name><name><surname>Pagnotta</surname><given-names>E.</given-names></name><name><surname>Valentino</surname><given-names>M. L.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993</article-title>. <source/>Biochim. Biophys. Acta
<volume>1767</volume>, <fpage>913</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2007.05.005</pub-id><pub-id pub-id-type="pmid">17568559</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Grau</surname><given-names>A.</given-names></name><name><surname>Bonaventura-Ibars</surname><given-names>I.</given-names></name><name><surname>Coll-Cantí</surname><given-names>J.</given-names></name><name><surname>Melià</surname><given-names>M. J.</given-names></name><name><surname>Martínez</surname><given-names>R.</given-names></name><name><surname>Martinez-Gallo</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Identification and biochemical characterization of the novel mutation m.8839G&gt;C in the mitochondrial ATP6 gene associated with NARP syndrome</article-title>. <source/>Genes Brain Behav.
<volume>12</volume>, <fpage>812</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1111/gbb.12089</pub-id><pub-id pub-id-type="pmid">24118886</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnefoy</surname><given-names>N.</given-names></name><name><surname>Fox</surname><given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Genetic transformation of <italic>Saccharomyces cerevisiae</italic> mitochondria</article-title>. <source/>Methods Cell Biol.
<volume>65</volume>, <fpage>381</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-679X(01)65022-2</pub-id><pub-id pub-id-type="pmid">11381605</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>P. D.</given-names></name></person-group> (<year>1997</year>). <article-title>The ATP synthase–a splendid molecular machine</article-title>. <source/>Annu. Rev. Biochem.
<volume>66</volume>, <fpage>717</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.66.1.717</pub-id><pub-id pub-id-type="pmid">9242922</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brum</surname><given-names>M.</given-names></name><name><surname>Semedo</surname><given-names>C.</given-names></name><name><surname>Guerreiro</surname><given-names>R.</given-names></name><name><surname>Pinto Marques</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Motor neuron syndrome as a new phenotypic manifestation of mutation 9185T&gt;C in gene MTATP6</article-title>. <source/>Case Rep. Neurol. Med.
<volume>2014</volume>:<fpage>701761</fpage>. <pub-id pub-id-type="doi">10.1155/2014/701761</pub-id><pub-id pub-id-type="pmid">25548692</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrage</surname><given-names>L. C.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Donti</surname><given-names>T. R.</given-names></name><name><surname>Walkiewicz</surname><given-names>M.</given-names></name><name><surname>Luchak</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G&gt;A) in the mitochondrial encoded ATP6 gene</article-title>. <source/>Mol. Genet. Metab.
<volume>113</volume>, <fpage>207</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2014.06.004</pub-id><pub-id pub-id-type="pmid">25037980</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>W.</given-names></name><name><surname>Fu</surname><given-names>Q.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Guan</surname><given-names>M. X.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial variants may influence the phenotypic manifestation of Leber's hereditary optic neuropathy-associated ND4 G11778A mutation</article-title>. <source/>J. Genet. Genomics
<volume>35</volume>, <fpage>649</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/S1673-8527(08)60086-7</pub-id><pub-id pub-id-type="pmid">19022198</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrozzo</surname><given-names>R.</given-names></name><name><surname>Rizza</surname><given-names>T.</given-names></name><name><surname>Stringaro</surname><given-names>A.</given-names></name><name><surname>Pierini</surname><given-names>R.</given-names></name><name><surname>Mormone</surname><given-names>E.</given-names></name><name><surname>Santorelli</surname><given-names>F. M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Maternally-inherited Leigh syndrome-related mutations bolster mitochondrial-mediated apoptosis</article-title>. <source/>J. Neurochem.
<volume>90</volume>, <fpage>490</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02505.x</pub-id><pub-id pub-id-type="pmid">15228605</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castagna</surname><given-names>A. E.</given-names></name><name><surname>Addis</surname><given-names>J.</given-names></name><name><surname>McInnes</surname><given-names>R. R.</given-names></name><name><surname>Clarke</surname><given-names>J. T.</given-names></name><name><surname>Ashby</surname><given-names>P.</given-names></name><name><surname>Blaser</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA</article-title>. <source/>Am. J. Med. Genet. A
<volume>143A</volume>, <fpage>808</fpage>–<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31637</pub-id><pub-id pub-id-type="pmid">17352390</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>A. M.</given-names></name><name><surname>Hutchin</surname><given-names>T.</given-names></name><name><surname>Pysden</surname><given-names>K.</given-names></name><name><surname>Highet</surname><given-names>L.</given-names></name><name><surname>Bamford</surname><given-names>J.</given-names></name><name><surname>Livingston</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Variable phenotype including Leigh syndrome with a 9185T&gt;C mutation in the MTATP6 gene</article-title>. <source/>Neuropediatrics
<volume>38</volume>, <fpage>313</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1055/s-2008-1065355</pub-id><pub-id pub-id-type="pmid">18461509</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinnery</surname><given-names>P. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial disease in adults: what's old and what's new?</article-title>
<source/>EMBO Mol. Med. <pub-id pub-id-type="doi">10.15252/emmm.201505079</pub-id><pub-id pub-id-type="pmid">26612854</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciafaloni</surname><given-names>E.</given-names></name><name><surname>Santorelli</surname><given-names>F. M.</given-names></name><name><surname>Shanske</surname><given-names>S.</given-names></name><name><surname>Deonna</surname><given-names>T.</given-names></name><name><surname>Roulet</surname><given-names>E.</given-names></name><name><surname>Janzer</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Maternally inherited Leigh syndrome</article-title>. <source/>J. Pediatr.
<volume>122</volume>, <fpage>419</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(05)83431-6</pub-id><pub-id pub-id-type="pmid">8095070</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortés-Hernández</surname><given-names>P.</given-names></name><name><surname>Vázquez-Memije</surname><given-names>M. E.</given-names></name><name><surname>García</surname><given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>ATP6 homoplasmic mutations inhibit and destabilize the human F<sub>1</sub>F<sub>o</sub>-ATP synthase without preventing enzyme assembly and oligomerization</article-title>. <source/>J. Biol. Chem.
<volume>282</volume>, <fpage>1051</fpage>–<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M606828200</pub-id><pub-id pub-id-type="pmid">17121862</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>K.</given-names></name><name><surname>Elliott</surname><given-names>H. R.</given-names></name><name><surname>Keers</surname><given-names>S. M.</given-names></name><name><surname>Lambert</surname><given-names>C.</given-names></name><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Graves</surname><given-names>T. D.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Episodic ataxia and hemiplegia caused by the 8993T→C mitochondrial DNA mutation</article-title>. <source/>J. Med. Genet.
<volume>44</volume>, <fpage>797</fpage>–<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.052902</pub-id><pub-id pub-id-type="pmid">18055910</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>K. M.</given-names></name><name><surname>Strauss</surname><given-names>M.</given-names></name><name><surname>Daum</surname><given-names>B.</given-names></name><name><surname>Kief</surname><given-names>J. H.</given-names></name><name><surname>Osiewacz</surname><given-names>H. D.</given-names></name><name><surname>Rycovska</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Macromolecular organization of ATP synthase and complex I in whole mitochondria</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>14121</fpage>–<lpage>14126</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1103621108</pub-id><pub-id pub-id-type="pmid">21836051</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Meirleir</surname><given-names>L.</given-names></name><name><surname>Seneca</surname><given-names>S.</given-names></name><name><surname>Lissens</surname><given-names>W.</given-names></name><name><surname>Schoentjes</surname><given-names>E.</given-names></name><name><surname>Desprechins</surname><given-names>B.</given-names></name></person-group> (<year>1995</year>). <article-title>Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene</article-title>. <source/>Pediatr. Neurol.
<volume>13</volume>, <fpage>242</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/0887-8994(95)00184-H</pub-id><pub-id pub-id-type="pmid">8554662</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vries</surname><given-names>D. D.</given-names></name><name><surname>Van Engelen</surname><given-names>B. G.</given-names></name><name><surname>Gabreëls</surname><given-names>F. J.</given-names></name><name><surname>Ruitenbeek</surname><given-names>W.</given-names></name><name><surname>Van Oost</surname><given-names>B. A.</given-names></name></person-group> (<year>1993</year>). <article-title>A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome</article-title>. <source/>Ann. Neurol.
<volume>34</volume>, <fpage>410</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410340319</pub-id><pub-id pub-id-type="pmid">8395787</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debray</surname><given-names>F. G.</given-names></name><name><surname>Lambert</surname><given-names>M.</given-names></name><name><surname>Lortie</surname><given-names>A.</given-names></name><name><surname>Vanasse</surname><given-names>M.</given-names></name><name><surname>Mitchell</surname><given-names>G. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Long-term outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation</article-title>. <source/>Am. J. Med. Genet. A
<volume>143A</volume>, <fpage>2046</fpage>–<lpage>2051</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31880</pub-id><pub-id pub-id-type="pmid">17663470</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimauro</surname><given-names>S.</given-names></name><name><surname>Schon</surname><given-names>E. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Mitochondrial respiratory-chain diseases</article-title>. <source/>N. Engl. J. Med.
<volume>348</volume>, <fpage>2656</fpage>–<lpage>2668</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra022567</pub-id><pub-id pub-id-type="pmid">12826641</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dionisi-Vici</surname><given-names>C.</given-names></name><name><surname>Seneca</surname><given-names>S.</given-names></name><name><surname>Zeviani</surname><given-names>M.</given-names></name><name><surname>Fariello</surname><given-names>G.</given-names></name><name><surname>Rimoldi</surname><given-names>M.</given-names></name><name><surname>Bertini</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>21</volume>, <fpage>2</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1023/A:1005397227996</pub-id><pub-id pub-id-type="pmid">9501263</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duno</surname><given-names>M.</given-names></name><name><surname>Wibrand</surname><given-names>F.</given-names></name><name><surname>Baggesen</surname><given-names>K.</given-names></name><name><surname>Rosenberg</surname><given-names>T.</given-names></name><name><surname>Kjaer</surname><given-names>N.</given-names></name><name><surname>Frederiksen</surname><given-names>A. L.</given-names></name></person-group> (<year>2013</year>). <article-title>A novel mitochondrial mutation m.8989G&gt;C associated with neuropathy, ataxia, retinitis pigmentosa - the NARP syndrome</article-title>. <source/>Gene
<volume>515</volume>, <fpage>372</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.12.066</pub-id><pub-id pub-id-type="pmid">23266623</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enns</surname><given-names>G. M.</given-names></name><name><surname>Bai</surname><given-names>R. K.</given-names></name><name><surname>Beck</surname><given-names>A. E.</given-names></name><name><surname>Wong</surname><given-names>L. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load</article-title>. <source/>Mol. Genet. Metab.
<volume>88</volume>, <fpage>364</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2006.02.001</pub-id><pub-id pub-id-type="pmid">16546428</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felhi</surname><given-names>R.</given-names></name><name><surname>Mkaouar-Rebai</surname><given-names>E.</given-names></name><name><surname>Sfaihi-Ben Mansour</surname><given-names>L.</given-names></name><name><surname>Alila-Fersi</surname><given-names>O.</given-names></name><name><surname>Tabebi</surname><given-names>M.</given-names></name><name><surname>Ben Rhouma</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Mutational analysis in patients with neuromuscular disorders: detection of mitochondrial deletion and double mutations in the MT-ATP6 gene</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>473</volume>, <fpage>61</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.03.050</pub-id><pub-id pub-id-type="pmid">26993169</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finsterer</surname><given-names>J.</given-names></name><name><surname>Stöllberger</surname><given-names>C.</given-names></name><name><surname>Schubert</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Acquired left ventricular hypertrabeculation/noncompaction in mitochondriopathy</article-title>. <source/>Cardiology
<volume>102</volume>, <fpage>228</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1159/000081015</pub-id><pub-id pub-id-type="pmid">15452396</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>T.</given-names></name><name><surname>Hattori</surname><given-names>H.</given-names></name><name><surname>Higuchi</surname><given-names>Y.</given-names></name><name><surname>Tsuji</surname><given-names>M.</given-names></name><name><surname>Mitsuyoshi</surname><given-names>I.</given-names></name></person-group> (<year>1998</year>). <article-title>Phenotypic differences between T→C and T→G mutations at nt 8993 of mitochondrial DNA in Leigh syndrome</article-title>. <source/>Pediatr. Neurol.
<volume>18</volume>, <fpage>275</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/S0887-8994(97)00187-2</pub-id><pub-id pub-id-type="pmid">9568930</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galimberti</surname><given-names>C. A.</given-names></name><name><surname>Diegoli</surname><given-names>M.</given-names></name><name><surname>Sartori</surname><given-names>I.</given-names></name><name><surname>Uggetti</surname><given-names>C.</given-names></name><name><surname>Brega</surname><given-names>A.</given-names></name><name><surname>Tartara</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation</article-title>. <source/>Neurology
<volume>67</volume>, <fpage>1715</fpage>–<lpage>1717</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000242882.58086.9a</pub-id><pub-id pub-id-type="pmid">17101920</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>J. J.</given-names></name><name><surname>Ogilvie</surname><given-names>I.</given-names></name><name><surname>Robinson</surname><given-names>B. H.</given-names></name><name><surname>Capaldi</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure, functioning, and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation. Comparison with the enzyme in Rho(0) cells completely lacking mtdna</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>11075</fpage>–<lpage>11081</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.15.11075</pub-id><pub-id pub-id-type="pmid">10753912</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goddard</surname><given-names>T. D.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Meng</surname><given-names>E. C.</given-names></name><name><surname>Pettersen</surname><given-names>E. F.</given-names></name><name><surname>Couch</surname><given-names>G. S.</given-names></name><name><surname>Morris</surname><given-names>J. H.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>UCSF ChimeraX: Meeting modern challenges in visualization and analysis</article-title>. <source/>Protein Sci.
<volume>27</volume>, <fpage>14</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1002/pro.3235</pub-id><pub-id pub-id-type="pmid">28710774</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greie</surname><given-names>J. C.</given-names></name><name><surname>Heitkamp</surname><given-names>T.</given-names></name><name><surname>Altendorf</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>The transmembrane domain of subunit b of the <italic>Escherichia coli</italic> F<sub>1</sub>F<sub>o</sub> ATP synthase is sufficient for H<sup>+</sup> translocating activity together with subunits a and c</article-title>. <source/>Eur. J. Biochem.
<volume>271</volume>, <fpage>3036</fpage>–<lpage>3042</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.2004.04235.x</pub-id><pub-id pub-id-type="pmid">15233800</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Bueler</surname><given-names>S. A.</given-names></name><name><surname>Rubinstein</surname><given-names>J. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Atomic model for the dimeric F<sub>o</sub> region of mitochondrial ATP synthase</article-title>. <source/>Science
<volume>358</volume>, <fpage>936</fpage>–<lpage>940</lpage>. <pub-id pub-id-type="doi">10.1126/science.aao4815</pub-id><pub-id pub-id-type="pmid">29074581</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurses</surname><given-names>C.</given-names></name><name><surname>Azakli</surname><given-names>H.</given-names></name><name><surname>Alptekin</surname><given-names>A.</given-names></name><name><surname>Cakiris</surname><given-names>A.</given-names></name><name><surname>Abaci</surname><given-names>N.</given-names></name><name><surname>Arikan</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis</article-title>. <source/>Gene
<volume>538</volume>, <fpage>323</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2014.01.030</pub-id><pub-id pub-id-type="pmid">24440288</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>A.</given-names></name><name><surname>Parey</surname><given-names>K.</given-names></name><name><surname>Bublitz</surname><given-names>M.</given-names></name><name><surname>Mills</surname><given-names>D. J.</given-names></name><name><surname>Zickermann</surname><given-names>V.</given-names></name><name><surname>Vonck</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Structure of a complete ATP synthase dimer reveals the molecular basis of inner mitochondrial membrane morphology</article-title>. <source/>Mol. Cell
<volume>63</volume>, <fpage>445</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2016.05.037</pub-id><pub-id pub-id-type="pmid">27373333</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hejzlarová</surname><given-names>K.</given-names></name><name><surname>Kaplanová</surname><given-names>V.</given-names></name><name><surname>Nusková</surname><given-names>H.</given-names></name><name><surname>Kovárová</surname><given-names>N.</given-names></name><name><surname>Ješina</surname><given-names>P.</given-names></name><name><surname>Drahota</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Alteration of structure and function of ATP synthase and cytochrome <italic>c</italic> oxidase by lack of F<sub>o</sub>-a and Cox3 subunits caused by mitochondrial DNA 9205delTA mutation</article-title>. <source/>Biochem. J.
<volume>466</volume>, <fpage>601</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20141462</pub-id><pub-id pub-id-type="pmid">25588698</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hejzlarova</surname><given-names>K.</given-names></name><name><surname>Mracek</surname><given-names>T.</given-names></name><name><surname>Vrbacky</surname><given-names>M.</given-names></name><name><surname>Kaplanova</surname><given-names>V.</given-names></name><name><surname>Karbanova</surname><given-names>V.</given-names></name><name><surname>Nuskova</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Nuclear genetic defects of mitochondrial ATP synthase</article-title>. <source/>Physiol. Res.
<volume>63</volume>(<issue>Suppl 1</issue>), <fpage>S57</fpage>–<lpage>S71</lpage>. <pub-id pub-id-type="pmid">24564666</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>I. J.</given-names></name><name><surname>Harding</surname><given-names>A. E.</given-names></name><name><surname>Petty</surname><given-names>R. K.</given-names></name><name><surname>Morgan-Hughes</surname><given-names>J. A.</given-names></name></person-group> (<year>1990</year>). <article-title>A new mitochondrial disease associated with mitochondrial DNA heteroplasmy</article-title>. <source/>Am. J. Hum. Genet.
<volume>46</volume>, <fpage>428</fpage>–<lpage>433</lpage>. <pub-id pub-id-type="pmid">2137962</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honzik</surname><given-names>T.</given-names></name><name><surname>Tesarova</surname><given-names>M.</given-names></name><name><surname>Magner</surname><given-names>M.</given-names></name><name><surname>Mayr</surname><given-names>J.</given-names></name><name><surname>Jesina</surname><given-names>P.</given-names></name><name><surname>Vesela</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>35</volume>, <fpage>749</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-011-9440-3</pub-id><pub-id pub-id-type="pmid">22231385</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honzik</surname><given-names>T.</given-names></name><name><surname>Tesarova</surname><given-names>M.</given-names></name><name><surname>Vinsova</surname><given-names>K.</given-names></name><name><surname>Hansikova</surname><given-names>H.</given-names></name><name><surname>Magner</surname><given-names>M.</given-names></name><name><surname>Kratochvilova</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Different laboratory and muscle biopsy findings in a family with an m.8851T&gt;C mutation in the mitochondrial MTATP6 gene</article-title>. <source/>Mol. Genet. Metab.
<volume>108</volume>, <fpage>102</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2012.11.002</pub-id><pub-id pub-id-type="pmid">23206802</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houstek</surname><given-names>J.</given-names></name><name><surname>Klement</surname><given-names>P.</given-names></name><name><surname>Hermanska</surname><given-names>J.</given-names></name><name><surname>Houstkova</surname><given-names>H.</given-names></name><name><surname>Hansikova</surname><given-names>H.</given-names></name><name><surname>Van Den Bogert</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Altered properties of mitochondrial ATP-synthase in patients with a T→G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA</article-title>. <source/>Biochim. Biophys. Acta
<volume>1271</volume>, <fpage>349</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/0925-4439(95)00063-A</pub-id><pub-id pub-id-type="pmid">7605802</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurvitz</surname><given-names>H.</given-names></name><name><surname>Naveh</surname><given-names>Y.</given-names></name><name><surname>Shoseyov</surname><given-names>D.</given-names></name><name><surname>Klar</surname><given-names>A.</given-names></name><name><surname>Shaag</surname><given-names>A.</given-names></name><name><surname>Elpeleg</surname><given-names>O.</given-names></name></person-group> (<year>2002</year>). <article-title>Transmission of the mitochondrial t8993c mutation in a new family</article-title>. <source/>Am. J. Med. Genet.
<volume>111</volume>, <fpage>446</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.10613</pub-id><pub-id pub-id-type="pmid">12210309</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>A.</given-names></name><name><surname>Fujita</surname><given-names>S.</given-names></name><name><surname>Kishita</surname><given-names>Y.</given-names></name><name><surname>Kohda</surname><given-names>M.</given-names></name><name><surname>Tokuzawa</surname><given-names>Y.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Rapidly progressive infantile cardiomyopathy with mitochondrial respiratory chain complex V deficiency due to loss of ATPase 6 and 8 protein</article-title>. <source/>Int. J. Cardiol.
<volume>207</volume>, <fpage>203</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.01.026</pub-id><pub-id pub-id-type="pmid">26803244</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>C. B.</given-names></name><name><surname>Hahn</surname><given-names>D.</given-names></name><name><surname>Schroter</surname><given-names>B.</given-names></name><name><surname>Richter</surname><given-names>U.</given-names></name><name><surname>Battersby</surname><given-names>B. J.</given-names></name><name><surname>Schmitt-Mechelke</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A novel mitochondrial ATP6 frameshift mutation causing isolated complex V deficiency, ataxia and encephalomyopathy</article-title>. <source/>Eur. J. Med. Genet.
<volume>60</volume>, <fpage>345</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2017.04.006</pub-id><pub-id pub-id-type="pmid">28412374</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>L. J.</given-names></name><name><surname>De Coo</surname><given-names>I. F.</given-names></name><name><surname>Nijland</surname><given-names>J. G.</given-names></name><name><surname>Galjaard</surname><given-names>R. J.</given-names></name><name><surname>Los</surname><given-names>F. J.</given-names></name><name><surname>Schoonderwoerd</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Transmission and prenatal diagnosis of the T9176C mitochondrial DNA mutation</article-title>. <source/>Mol. Hum. Reprod.
<volume>11</volume>, <fpage>223</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gah152</pub-id><pub-id pub-id-type="pmid">15709156</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesina</surname><given-names>P.</given-names></name><name><surname>Tesarova</surname><given-names>M.</given-names></name><name><surname>Fornuskova</surname><given-names>D.</given-names></name><name><surname>Vojtiskova</surname><given-names>A.</given-names></name><name><surname>Pecina</surname><given-names>P.</given-names></name><name><surname>Kaplanova</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206</article-title>. <source/>Biochem. J.
<volume>383</volume>, <fpage>561</fpage>–<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20040407</pub-id><pub-id pub-id-type="pmid">15265003</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonckheere</surname><given-names>A. I.</given-names></name><name><surname>Hogeveen</surname><given-names>M.</given-names></name><name><surname>Nijtmans</surname><given-names>L. G.</given-names></name><name><surname>Van Den Brand</surname><given-names>M. A.</given-names></name><name><surname>Janssen</surname><given-names>A. J.</given-names></name><name><surname>Diepstra</surname><given-names>J. H.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy</article-title>. <source/>J. Med. Genet.
<volume>45</volume>, <fpage>129</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.052084</pub-id><pub-id pub-id-type="pmid">17954552</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonckheere</surname><given-names>A. I.</given-names></name><name><surname>Smeitink</surname><given-names>J. A.</given-names></name><name><surname>Rodenburg</surname><given-names>R. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial ATP synthase: architecture, function and pathology</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>35</volume>, <fpage>211</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-011-9382-9</pub-id><pub-id pub-id-type="pmid">21874297</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junge</surname><given-names>W.</given-names></name><name><surname>Lill</surname><given-names>H.</given-names></name><name><surname>Engelbrecht</surname><given-names>S.</given-names></name></person-group> (<year>1997</year>). <article-title>ATP synthase: an electrochemical transducer with rotatory mechanics</article-title>. <source/>Trends Biochem. Sci.
<volume>22</volume>, <fpage>420</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/S0968-0004(97)01129-8</pub-id><pub-id pub-id-type="pmid">9397682</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabala</surname><given-names>A. M.</given-names></name><name><surname>Lasserre</surname><given-names>J. P.</given-names></name><name><surname>Ackerman</surname><given-names>S. H.</given-names></name><name><surname>Di Rago</surname><given-names>J. P.</given-names></name><name><surname>Kucharczyk</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Defining the impact on yeast ATP synthase of two pathogenic human mitochondrial DNA mutations, T9185C and T9191C</article-title>. <source/>Biochimie
<volume>100</volume>, <fpage>200</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2013.11.024</pub-id><pub-id pub-id-type="pmid">24316278</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>B.</given-names></name><name><surname>Arikan</surname><given-names>M.</given-names></name><name><surname>Maras</surname><given-names>H.</given-names></name><name><surname>Abaci</surname><given-names>N.</given-names></name><name><surname>Cakiris</surname><given-names>A.</given-names></name><name><surname>Ustek</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T&gt;C mutation in the MT-ATP6 gene</article-title>. <source/>Mol. Genet. Metab.
<volume>107</volume>, <fpage>389</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2012.06.013</pub-id><pub-id pub-id-type="pmid">22819295</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>M. P.</given-names></name><name><surname>Attardi</surname><given-names>G.</given-names></name></person-group> (<year>1989</year>). <article-title>Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation</article-title>. <source/>Science
<volume>246</volume>, <fpage>500</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1126/science.2814477</pub-id><pub-id pub-id-type="pmid">2814477</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korshunov</surname><given-names>S. S.</given-names></name><name><surname>Skulachev</surname><given-names>V. P.</given-names></name><name><surname>Starkov</surname><given-names>A. A.</given-names></name></person-group> (<year>1997</year>). <article-title>High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria</article-title>. <source/>FEBS Lett.
<volume>416</volume>, <fpage>15</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(97)01159-9</pub-id><pub-id pub-id-type="pmid">9369223</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Ezkurdia</surname><given-names>N.</given-names></name><name><surname>Couplan</surname><given-names>E.</given-names></name><name><surname>Procaccio</surname><given-names>V.</given-names></name><name><surname>Ackerman</surname><given-names>S. H.</given-names></name><name><surname>Blondel</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Consequences of the pathogenic T9176C mutation of human mitochondrial DNA on yeast mitochondrial ATP synthase</article-title>. <source/>Biochim. Biophys. Acta
<volume>1797</volume>, <fpage>1105</fpage>–<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2009.12.022</pub-id><pub-id pub-id-type="pmid">20056103</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Giraud</surname><given-names>M. F.</given-names></name><name><surname>Brethes</surname><given-names>D.</given-names></name><name><surname>Wysocka-Kapcinska</surname><given-names>M.</given-names></name><name><surname>Ezkurdia</surname><given-names>N.</given-names></name><name><surname>Salin</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Defining the pathogenesis of human mtDNA mutations using a yeast model: the case of T8851C</article-title>. <source/>Int. J. Biochem. Cell Biol.
<volume>45</volume>, <fpage>130</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2012.07.001</pub-id><pub-id pub-id-type="pmid">22789932</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Rak</surname><given-names>M.</given-names></name><name><surname>Di Rago</surname><given-names>J. P.</given-names></name></person-group> (<year>2009a</year>). <article-title>Biochemical consequences in yeast of the human mitochondrial DNA 8993T&gt;C mutation in the ATPase6 gene found in NARP/MILS patients</article-title>. <source/>Biochim. Biophys. Acta
<volume>1793</volume>, <fpage>817</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2009.02.011</pub-id><pub-id pub-id-type="pmid">19269308</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Salin</surname><given-names>B.</given-names></name><name><surname>Di Rago</surname><given-names>J. P.</given-names></name></person-group> (<year>2009b</year>). <article-title>Introducing the human Leigh syndrome mutation T9176G into <italic>Saccharomyces cerevisiae</italic> mitochondrial DNA leads to severe defects in the incorporation of Atp6p into the ATP synthase and in the mitochondrial morphology</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume>, <fpage>2889</fpage>–<lpage>2898</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp226</pub-id><pub-id pub-id-type="pmid">19454486</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Zick</surname><given-names>M.</given-names></name><name><surname>Bietenhader</surname><given-names>M.</given-names></name><name><surname>Rak</surname><given-names>M.</given-names></name><name><surname>Couplan</surname><given-names>E.</given-names></name><name><surname>Blondel</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009c</year>). <article-title>Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches</article-title>. <source/>Biochim. Biophys. Acta
<volume>1793</volume>, <fpage>186</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2008.06.012</pub-id><pub-id pub-id-type="pmid">18620007</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühlbrandt</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Biochemistry. The resolution revolution</article-title>. <source/>Science
<volume>343</volume>, <fpage>1443</fpage>–<lpage>1444</lpage>. <pub-id pub-id-type="doi">10.1126/science.1251652</pub-id><pub-id pub-id-type="pmid">24675944</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Tanwar</surname><given-names>M.</given-names></name><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Dada</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy</article-title>. <source/>Mol. Vis.
<volume>16</volume>, <fpage>782</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="pmid">20454697</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kytovuori</surname><given-names>L.</given-names></name><name><surname>Lipponen</surname><given-names>J.</given-names></name><name><surname>Rusanen</surname><given-names>H.</given-names></name><name><surname>Komulainen</surname><given-names>T.</given-names></name><name><surname>Martikainen</surname><given-names>M. H.</given-names></name><name><surname>Majamaa</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>A novel mutation m.8561C&gt;G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism</article-title>. <source/>J. Neurol.
<volume>263</volume>, <fpage>2188</fpage>–<lpage>2195</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-016-8249-2</pub-id><pub-id pub-id-type="pmid">27502083</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Morgia</surname><given-names>C.</given-names></name><name><surname>Achilli</surname><given-names>A.</given-names></name><name><surname>Iommarini</surname><given-names>L.</given-names></name><name><surname>Barboni</surname><given-names>P.</given-names></name><name><surname>Pala</surname><given-names>M.</given-names></name><name><surname>Olivieri</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus</article-title>. <source/>Neurology
<volume>70</volume>, <fpage>762</fpage>–<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000295505.74234.d0</pub-id><pub-id pub-id-type="pmid">18216301</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamminen</surname><given-names>T.</given-names></name><name><surname>Majander</surname><given-names>A.</given-names></name><name><surname>Juvonen</surname><given-names>V.</given-names></name><name><surname>Wikstrom</surname><given-names>M.</given-names></name><name><surname>Aula</surname><given-names>P.</given-names></name><name><surname>Nikoskelainen</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy</article-title>. <source/>Am. J. Hum. Genet.
<volume>56</volume>, <fpage>1238</fpage>–<lpage>1240</lpage>. <pub-id pub-id-type="pmid">7726182</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasserre</surname><given-names>J. P.</given-names></name><name><surname>Dautant</surname><given-names>A.</given-names></name><name><surname>Aiyar</surname><given-names>R. S.</given-names></name><name><surname>Kucharczyk</surname><given-names>R.</given-names></name><name><surname>Glatigny</surname><given-names>A.</given-names></name><name><surname>Tribouillard-Tanvier</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies</article-title>. <source/>Dis. Model. Mech.
<volume>8</volume>, <fpage>509</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.020438</pub-id><pub-id pub-id-type="pmid">26035862</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Gallardo</surname><given-names>E.</given-names></name><name><surname>Emperador</surname><given-names>S.</given-names></name><name><surname>Solano</surname><given-names>A.</given-names></name><name><surname>Llobet</surname><given-names>L.</given-names></name><name><surname>Martin-Navarro</surname><given-names>A.</given-names></name><name><surname>Lopez-Perez</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Expanding the clinical phenotypes of MT-ATP6 mutations</article-title>. <source/>Hum. Mol. Genet.
<volume>23</volume>, <fpage>6191</fpage>–<lpage>6200</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu339</pub-id><pub-id pub-id-type="pmid">24986921</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Gallardo</surname><given-names>E.</given-names></name><name><surname>Solano</surname><given-names>A.</given-names></name><name><surname>Herrero-Martin</surname><given-names>M. D.</given-names></name><name><surname>Martinez-Romero</surname><given-names>I.</given-names></name><name><surname>Castano-Perez</surname><given-names>M. D.</given-names></name><name><surname>Andreu</surname><given-names>A. L.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein</article-title>. <source/>J. Med. Genet.
<volume>46</volume>, <fpage>64</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.060616</pub-id><pub-id pub-id-type="pmid">19124644</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lott</surname><given-names>M. T.</given-names></name><name><surname>Leipzig</surname><given-names>J. N.</given-names></name><name><surname>Derbeneva</surname><given-names>O.</given-names></name><name><surname>Xie</surname><given-names>H. M.</given-names></name><name><surname>Chalkia</surname><given-names>D.</given-names></name><name><surname>Sarmady</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>mtDNA variation and analysis using MITOMAP and MITOMASTER</article-title>. <source/>Curr. Protoc. Bioinformatics
<fpage>1.23.1</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi0123s44</pub-id><pub-id pub-id-type="pmid">25489354</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majander</surname><given-names>A.</given-names></name><name><surname>Lamminen</surname><given-names>T.</given-names></name><name><surname>Juvonen</surname><given-names>V.</given-names></name><name><surname>Aula</surname><given-names>P.</given-names></name><name><surname>Nikoskelainen</surname><given-names>E.</given-names></name><name><surname>Savontaus</surname><given-names>M. L.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Mutations in subunit 6 of the F<sub>1</sub>F<sub>o</sub>-ATP synthase cause two entirely different diseases</article-title>. <source/>FEBS Lett.
<volume>412</volume>, <fpage>351</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(97)00757-6</pub-id><pub-id pub-id-type="pmid">9256250</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makino</surname><given-names>M.</given-names></name><name><surname>Horai</surname><given-names>S.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>Nonaka</surname><given-names>I.</given-names></name></person-group> (<year>1998</year>). <article-title>Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome</article-title>. <source/>Neuromuscul. Disord.
<volume>8</volume>, <fpage>149</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-8966(98)00017-0</pub-id><pub-id pub-id-type="pmid">9631394</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martikainen</surname><given-names>M. H.</given-names></name><name><surname>Gorman</surname><given-names>G. S.</given-names></name><name><surname>Goldsmith</surname><given-names>P.</given-names></name><name><surname>Burn</surname><given-names>D. J.</given-names></name><name><surname>Turnbull</surname><given-names>D. M.</given-names></name><name><surname>Schaefer</surname><given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Adult-onset myoclonus ataxia associated with the mitochondrial m.8993T&gt;C “NARP” mutation</article-title>. <source/>Mov. Disord.
<volume>30</volume>, <fpage>1432</fpage>–<lpage>1433</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26358</pub-id><pub-id pub-id-type="pmid">26265210</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiazzi</surname><given-names>M.</given-names></name><name><surname>Vijayvergiya</surname><given-names>C.</given-names></name><name><surname>Gajewski</surname><given-names>C. D.</given-names></name><name><surname>Devivo</surname><given-names>D. C.</given-names></name><name><surname>Lenaz</surname><given-names>G.</given-names></name><name><surname>Wiedmann</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume>, <fpage>869</fpage>–<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh103</pub-id><pub-id pub-id-type="pmid">14998933</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>F. J.</given-names></name><name><surname>Rosenfeldt</surname><given-names>F. L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Linnane</surname><given-names>A. W.</given-names></name><name><surname>Nagley</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age</article-title>. <source/>Nucleic Acids Res.
<volume>31</volume>:<fpage>e61</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gng060</pub-id><pub-id pub-id-type="pmid">12771225</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitome</surname><given-names>N.</given-names></name><name><surname>Ono</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Sone</surname><given-names>N.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Essential arginine residue of the F<sub>o</sub>-<italic>a</italic> subunit in F<sub>o</sub>F<sub>1</sub>-ATP synthase has a role to prevent the proton shortcut without c-ring rotation in the F<sub>o</sub> proton channel</article-title>. <source/>Biochem. J.
<volume>430</volume>, <fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20100621</pub-id><pub-id pub-id-type="pmid">20518749</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mkaouar-Rebai</surname><given-names>E.</given-names></name><name><surname>Kammoun</surname><given-names>F.</given-names></name><name><surname>Chamkha</surname><given-names>I.</given-names></name><name><surname>Kammoun</surname><given-names>N.</given-names></name><name><surname>Hsairi</surname><given-names>I.</given-names></name><name><surname>Triki</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A de novo mutation in the adenosine triphosphatase (ATPase) 8 gene in a patient with mitochondrial disorder</article-title>. <source/>J. Child Neurol.
<volume>25</volume>, <fpage>770</fpage>–<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1177/0883073809344351</pub-id><pub-id pub-id-type="pmid">20207608</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Rios</surname><given-names>E.</given-names></name><name><surname>Montgomery</surname><given-names>M. G.</given-names></name><name><surname>Leslie</surname><given-names>A. G.</given-names></name><name><surname>Walker</surname><given-names>J. E.</given-names></name></person-group> (<year>2015a</year>). <article-title>Structure of ATP synthase from <italic>Paracoccus denitrificans</italic> determined by X-ray crystallography at 4.0 Å resolution</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>13231</fpage>–<lpage>13236</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1517542112</pub-id><pub-id pub-id-type="pmid">26460036</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Rios</surname><given-names>E.</given-names></name><name><surname>Montgomery</surname><given-names>M. G.</given-names></name><name><surname>Leslie</surname><given-names>A. G.</given-names></name><name><surname>Garcia-Trejo</surname><given-names>J. J.</given-names></name><name><surname>Walker</surname><given-names>J. E.</given-names></name></person-group> (<year>2015b</year>). <article-title>Structure of a catalytic dimer of the α- and β-subunits of the F-ATPase from <italic>Paracoccus denitrificans</italic> at 2.3 A resolution</article-title>. <source/>Acta Crystallogr. F Struct. Biol. Commun.
<volume>71</volume>, <fpage>1309</fpage>–<lpage>1317</lpage>. <pub-id pub-id-type="doi">10.1107/S2053230X15016076</pub-id><pub-id pub-id-type="pmid">26457523</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morava</surname><given-names>E.</given-names></name><name><surname>Rodenburg</surname><given-names>R. J.</given-names></name><name><surname>Hol</surname><given-names>F.</given-names></name><name><surname>De Vries</surname><given-names>M.</given-names></name><name><surname>Janssen</surname><given-names>A.</given-names></name><name><surname>Van Den Heuvel</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Clinical and biochemical characteristics in patients with a high mutant load of the mitochondrial T8993G/C mutations</article-title>. <source/>Am. J. Med. Genet. A
<volume>140</volume>, <fpage>863</fpage>–<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31194</pub-id><pub-id pub-id-type="pmid">16532470</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordel</surname><given-names>P.</given-names></name><name><surname>Schaeffer</surname><given-names>S.</given-names></name><name><surname>Dupas</surname><given-names>Q.</given-names></name><name><surname>Laville</surname><given-names>M. A.</given-names></name><name><surname>Gerard</surname><given-names>M.</given-names></name><name><surname>Chapon</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A 2 bp deletion in the mitochondrial ATP 6 gene responsible for the NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>494</volume>, <fpage>133</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.10.066</pub-id><pub-id pub-id-type="pmid">29054413</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moslemi</surname><given-names>A. R.</given-names></name><name><surname>Darin</surname><given-names>N.</given-names></name><name><surname>Tulinius</surname><given-names>M.</given-names></name><name><surname>Oldfors</surname><given-names>A.</given-names></name><name><surname>Holme</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Two new mutations in the MTATP6 gene associated with Leigh syndrome</article-title>. <source/>Neuropediatrics
<volume>36</volume>, <fpage>314</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1055/s-2005-872845</pub-id><pub-id pub-id-type="pmid">16217706</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Y. S.</given-names></name><name><surname>Turnbull</surname><given-names>D. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial disease: genetics and management</article-title>. <source/>J. Neurol.
<volume>263</volume>, <fpage>179</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-015-7884-3</pub-id>. <pub-id pub-id-type="pmid">26315846</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedzwiecka</surname><given-names>K.</given-names></name><name><surname>Kabala</surname><given-names>A. M.</given-names></name><name><surname>Lasserre</surname><given-names>J. P.</given-names></name><name><surname>Tribouillard-Tanvier</surname><given-names>D.</given-names></name><name><surname>Golik</surname><given-names>P.</given-names></name><name><surname>Dautant</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Yeast models of mutations in the mitochondrial ATP6 gene found in human cancer cells</article-title>. <source/>Mitochondrion
<volume>29</volume>, <fpage>7</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2016.04.003</pub-id><pub-id pub-id-type="pmid">27083309</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijtmans</surname><given-names>L. G.</given-names></name><name><surname>Henderson</surname><given-names>N. S.</given-names></name><name><surname>Attardi</surname><given-names>G.</given-names></name><name><surname>Holt</surname><given-names>I. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>6755</fpage>–<lpage>6762</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M008114200</pub-id><pub-id pub-id-type="pmid">11076946</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Perlman</surname><given-names>P. S.</given-names></name><name><surname>Butow</surname><given-names>R. A.</given-names></name></person-group> (<year>1998</year>). <article-title>The sorting of mitochondrial DNA and mitochondrial proteins in zygotes: preferential transmission of mitochondrial DNA to the medial bud</article-title>. <source/>J. Cell Biol.
<volume>142</volume>, <fpage>613</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.142.3.613</pub-id><pub-id pub-id-type="pmid">9700153</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliarini</surname><given-names>D. J.</given-names></name><name><surname>Calvo</surname><given-names>S. E.</given-names></name><name><surname>Chang</surname><given-names>B.</given-names></name><name><surname>Sheth</surname><given-names>S. A.</given-names></name><name><surname>Vafai</surname><given-names>S. B.</given-names></name><name><surname>Ong</surname><given-names>S. E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A mitochondrial protein compendium elucidates complex I disease biology</article-title>. <source/>Cell
<volume>134</volume>, <fpage>112</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.06.016</pub-id><pub-id pub-id-type="pmid">18614015</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallotti</surname><given-names>F.</given-names></name><name><surname>Baracca</surname><given-names>A.</given-names></name><name><surname>Hernandez-Rosa</surname><given-names>E.</given-names></name><name><surname>Walker</surname><given-names>W. F.</given-names></name><name><surname>Solaini</surname><given-names>G.</given-names></name><name><surname>Lenaz</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations</article-title>. <source/>Biochem. J.
<volume>384</volume>, <fpage>287</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20040561</pub-id><pub-id pub-id-type="pmid">15324306</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>D. F.</given-names></name></person-group> (<year>1963</year>). <article-title>Mitochondrial structure: two types of subunits on negatively stained mitochondrial membranes</article-title>. <source/>Science
<volume>140</volume>, <fpage>985</fpage>–<lpage>987</lpage>. <pub-id pub-id-type="doi">10.1126/science.140.3570.985</pub-id><pub-id pub-id-type="pmid">17836486</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paumard</surname><given-names>P.</given-names></name><name><surname>Vaillier</surname><given-names>J.</given-names></name><name><surname>Coulary</surname><given-names>B.</given-names></name><name><surname>Schaeffer</surname><given-names>J.</given-names></name><name><surname>Soubannier</surname><given-names>V.</given-names></name><name><surname>Mueller</surname><given-names>D. M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>The ATP synthase is involved in generating mitochondrial cristae morphology</article-title>. <source/>EMBO J.
<volume>21</volume>, <fpage>221</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/21.3.221</pub-id><pub-id pub-id-type="pmid">11823415</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perucca-Lostanlen</surname><given-names>D.</given-names></name><name><surname>Narbonne</surname><given-names>H.</given-names></name><name><surname>Hernandez</surname><given-names>J. B.</given-names></name><name><surname>Staccini</surname><given-names>P.</given-names></name><name><surname>Saunieres</surname><given-names>A.</given-names></name><name><surname>Paquis-Flucklinger</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Mitochondrial DNA variations in patients with maternally inherited diabetes and deafness syndrome</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>277</volume>, <fpage>771</fpage>–<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2000.3751</pub-id><pub-id pub-id-type="pmid">11062027</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petros</surname><given-names>J. A.</given-names></name><name><surname>Baumann</surname><given-names>A. K.</given-names></name><name><surname>Ruiz-Pesini</surname><given-names>E.</given-names></name><name><surname>Amin</surname><given-names>M. B.</given-names></name><name><surname>Sun</surname><given-names>C. Q.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>mtDNA mutations increase tumorigenicity in prostate cancer</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>102</volume>, <fpage>719</fpage>–<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0408894102</pub-id><pub-id pub-id-type="pmid">15647368</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>G.</given-names></name><name><surname>Blakely</surname><given-names>E. L.</given-names></name><name><surname>Alston</surname><given-names>C. L.</given-names></name><name><surname>Hassani</surname><given-names>A.</given-names></name><name><surname>Boggild</surname><given-names>M.</given-names></name><name><surname>Horvath</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Adult-onset spinocerebellar ataxia syndromes due to MTATP6 mutations</article-title>. <source/>J. Neurol. Neurosurg. Psychiatr.
<volume>83</volume>, <fpage>883</fpage>–<lpage>886</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-302568</pub-id><pub-id pub-id-type="pmid">22577227</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piryaei</surname><given-names>F.</given-names></name><name><surname>Houshmand</surname><given-names>M.</given-names></name><name><surname>Aryani</surname><given-names>O.</given-names></name><name><surname>Dadgar</surname><given-names>S.</given-names></name><name><surname>Soheili</surname><given-names>Z. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Investigation of the Mitochondrial ATPase 6/8 and tRNA(Lys) Genes Mutations in Autism</article-title>. <source/>Cell J.
<volume>14</volume>, <fpage>98</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="pmid">23508290</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitceathly</surname><given-names>R. D.</given-names></name><name><surname>Murphy</surname><given-names>S. M.</given-names></name><name><surname>Cottenie</surname><given-names>E.</given-names></name><name><surname>Chalasani</surname><given-names>A.</given-names></name><name><surname>Sweeney</surname><given-names>M. G.</given-names></name><name><surname>Woodward</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Genetic dysfunction of MT-ATP6 causes axonal charcot-marie-tooth disease</article-title>. <source/>Neurology
<volume>79</volume>, <fpage>1145</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182698d8d</pub-id><pub-id pub-id-type="pmid">22933740</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogoryelov</surname><given-names>D.</given-names></name><name><surname>Krah</surname><given-names>A.</given-names></name><name><surname>Langer</surname><given-names>J. D.</given-names></name><name><surname>Yildiz</surname><given-names>Ö.</given-names></name><name><surname>Faraldo-Gómez</surname><given-names>J. D.</given-names></name><name><surname>Meier</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Microscopic rotary mechanism of ion translocation in the F<sub>o</sub> complex of ATP synthases</article-title>. <source/>Nat. Chem. Biol.
<volume>6</volume>, <fpage>891</fpage>–<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.457</pub-id><pub-id pub-id-type="pmid">20972431</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Povalko</surname><given-names>N.</given-names></name><name><surname>Zakharova</surname><given-names>E.</given-names></name><name><surname>Rudenskaia</surname><given-names>G.</given-names></name><name><surname>Akita</surname><given-names>Y.</given-names></name><name><surname>Hirata</surname><given-names>K.</given-names></name><name><surname>Toyojiro</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>A new sequence variant in mitochondrial DNA associated with high penetrance of Russian Leber hereditary optic neuropathy</article-title>. <source/>Mitochondrion
<volume>5</volume>, <fpage>194</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2005.03.003</pub-id><pub-id pub-id-type="pmid">16050984</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prokisch</surname><given-names>H.</given-names></name><name><surname>Scharfe</surname><given-names>C.</given-names></name><name><surname>Camp</surname><given-names>D. G.</given-names><suffix>II.</suffix></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>David</surname><given-names>L.</given-names></name><name><surname>Andreoli</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Integrative analysis of the mitochondrial proteome in yeast</article-title>. <source/>PLoS Biol.
<volume>2</volume>:<fpage>e160</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0020160</pub-id><pub-id pub-id-type="pmid">15208715</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puddu</surname><given-names>P.</given-names></name><name><surname>Barboni</surname><given-names>P.</given-names></name><name><surname>Mantovani</surname><given-names>V.</given-names></name><name><surname>Montagna</surname><given-names>P.</given-names></name><name><surname>Cerullo</surname><given-names>A.</given-names></name><name><surname>Bragliani</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Retinitis pigmentosa, ataxia, and mental retardation associated with mitochondrial DNA mutation in an Italian family</article-title>. <source/>Br. J. Ophthalmol.
<volume>77</volume>, <fpage>84</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1136/bjo.77.2.84</pub-id><pub-id pub-id-type="pmid">8435424</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rak</surname><given-names>M.</given-names></name><name><surname>Tetaud</surname><given-names>E.</given-names></name><name><surname>Duvezin-Caubet</surname><given-names>S.</given-names></name><name><surname>Ezkurdia</surname><given-names>N.</given-names></name><name><surname>Bietenhader</surname><given-names>M.</given-names></name><name><surname>Rytka</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene</article-title>. <source/>J. Biol. Chem.
<volume>282</volume>, <fpage>34039</fpage>–<lpage>34047</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M703053200</pub-id><pub-id pub-id-type="pmid">17855363</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinders</surname><given-names>J.</given-names></name><name><surname>Zahedi</surname><given-names>R. P.</given-names></name><name><surname>Pfanner</surname><given-names>N.</given-names></name><name><surname>Meisinger</surname><given-names>C.</given-names></name><name><surname>Sickmann</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Toward the complete yeast mitochondrial proteome: multidimensional separation techniques for mitochondrial proteomics</article-title>. <source/>J. Proteome Res.
<volume>5</volume>, <fpage>1543</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1021/pr050477f</pub-id><pub-id pub-id-type="pmid">16823961</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>H. W.</given-names></name><name><surname>Zou</surname><given-names>P.</given-names></name><name><surname>Udeshi</surname><given-names>N. D.</given-names></name><name><surname>Martell</surname><given-names>J. D.</given-names></name><name><surname>Mootha</surname><given-names>V. K.</given-names></name><name><surname>Carr</surname><given-names>S. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging</article-title>. <source/>Science
<volume>339</volume>, <fpage>1328</fpage>–<lpage>1331</lpage>. <pub-id pub-id-type="doi">10.1126/science.1230593</pub-id><pub-id pub-id-type="pmid">23371551</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojo</surname><given-names>A.</given-names></name><name><surname>Campos</surname><given-names>Y.</given-names></name><name><surname>Sanchez</surname><given-names>J. M.</given-names></name><name><surname>Bonaventura</surname><given-names>I.</given-names></name><name><surname>Aguilar</surname><given-names>M.</given-names></name><name><surname>Garcia</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>NARP-MILS syndrome caused by 8993 T&gt;G mitochondrial DNA mutation: a clinical, genetic and neuropathological study</article-title>. <source/>Acta Neuropathol.
<volume>111</volume>, <fpage>610</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-006-0040-5</pub-id><pub-id pub-id-type="pmid">16525806</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronchi</surname><given-names>D.</given-names></name><name><surname>Bordoni</surname><given-names>A.</given-names></name><name><surname>Cosi</surname><given-names>A.</given-names></name><name><surname>Rizzuti</surname><given-names>M.</given-names></name><name><surname>Fassone</surname><given-names>E.</given-names></name><name><surname>Di Fonzo</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Unusual adult-onset Leigh syndrome presentation due to the mitochondrial m.9176T&gt;C mutation</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>412</volume>, <fpage>245</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2011.07.076</pub-id><pub-id pub-id-type="pmid">21819970</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Kaga</surname><given-names>K.</given-names></name><name><surname>Kodama</surname><given-names>K.</given-names></name><name><surname>Higuchi</surname><given-names>A.</given-names></name><name><surname>Miyamoto</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Hearing evaluation in two sisters with a T8993G point mutation of mitochondrial DNA</article-title>. <source/>Int. J. Pediatr. Otorhinolaryngol.
<volume>68</volume>, <fpage>1115</fpage>–<lpage>1119</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijporl.2004.03.015</pub-id><pub-id pub-id-type="pmid">15236904</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saneto</surname><given-names>R. P.</given-names></name><name><surname>Singh</surname><given-names>K. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T&gt;C</article-title>. <source/>Mitochondrion
<volume>10</volume>, <fpage>567</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.05.006</pub-id><pub-id pub-id-type="pmid">20546952</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santorelli</surname><given-names>F. M.</given-names></name><name><surname>Shanske</surname><given-names>S.</given-names></name><name><surname>Jain</surname><given-names>K. D.</given-names></name><name><surname>Tick</surname><given-names>D.</given-names></name><name><surname>Schon</surname><given-names>E. A.</given-names></name><name><surname>Dimauro</surname><given-names>S.</given-names></name></person-group> (<year>1994</year>). <article-title>A T→C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome</article-title>. <source/>Neurology
<volume>44</volume>, <fpage>972</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.44.5.972</pub-id><pub-id pub-id-type="pmid">8190310</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraste</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Oxidative phosphorylation at the fin de siecle</article-title>. <source/>Science
<volume>283</volume>, <fpage>1488</fpage>–<lpage>1493</lpage>. <pub-id pub-id-type="doi">10.1126/science.283.5407.1488</pub-id><pub-id pub-id-type="pmid">10066163</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schägger</surname><given-names>H.</given-names></name><name><surname>Pfeiffer</surname><given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Supercomplexes in the respiratory chains of yeast and mammalian mitochondria</article-title>. <source/>EMBO J.
<volume>19</volume>, <fpage>1777</fpage>–<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.8.1777</pub-id><pub-id pub-id-type="pmid">10775262</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>E.</given-names></name><name><surname>Altendorf</surname><given-names>K.</given-names></name></person-group> (<year>1984</year>). <article-title>Subunit <italic>b</italic> of the membrane moiety F<sub>o</sub> of ATP synthase (F<sub>1</sub>F<sub>o</sub>) from <italic>Escherichia coli</italic> is indispensable for H<sup>+</sup> translocation and binding of the water-soluble F<sub>1</sub> moiety</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>81</volume>, <fpage>7279</fpage>–<lpage>7283</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.81.23.7279</pub-id><pub-id pub-id-type="pmid">6209711</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>E.</given-names></name><name><surname>Altendorf</surname><given-names>K.</given-names></name></person-group> (<year>1985</year>). <article-title>Modification of subunit b of the F<sub>o</sub> complex from <italic>Escherichia coli</italic> ATP synthase by a hydrophobic maleimide and its effects on F<sub>o</sub> functions</article-title>. <source/>Eur. J. Biochem.
<volume>153</volume>, <fpage>105</fpage>–<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1985.tb09274.x</pub-id><pub-id pub-id-type="pmid">2866095</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seneca</surname><given-names>S.</given-names></name><name><surname>Abramowicz</surname><given-names>M.</given-names></name><name><surname>Lissens</surname><given-names>W.</given-names></name><name><surname>Muller</surname><given-names>M. F.</given-names></name><name><surname>Vamos</surname><given-names>E.</given-names></name><name><surname>De Meirleir</surname><given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>A mitochondrial DNA microdeletion in a newborn girl with transient lactic acidosis</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>19</volume>, <fpage>115</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1007/BF01799407</pub-id><pub-id pub-id-type="pmid">8739943</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sequeira</surname><given-names>A.</given-names></name><name><surname>Rollins</surname><given-names>B.</given-names></name><name><surname>Magnan</surname><given-names>C.</given-names></name><name><surname>Van Oven</surname><given-names>M.</given-names></name><name><surname>Baldi</surname><given-names>P.</given-names></name><name><surname>Myers</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Mitochondrial mutations in subjects with psychiatric disorders</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0127280</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0127280</pub-id><pub-id pub-id-type="pmid">26011537</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sgarbi</surname><given-names>G.</given-names></name><name><surname>Baracca</surname><given-names>A.</given-names></name><name><surname>Lenaz</surname><given-names>G.</given-names></name><name><surname>Valentino</surname><given-names>L. M.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Solaini</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in mtDNA</article-title>. <source/>Biochem. J.
<volume>395</volume>, <fpage>493</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20051748</pub-id><pub-id pub-id-type="pmid">16402916</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shidara</surname><given-names>K.</given-names></name><name><surname>Wakakura</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Leber's hereditary optic neuropathy with the 3434, 9011 mitochondrial DNA point mutation</article-title>. <source/>Jpn. J. Ophthalmol.
<volume>56</volume>, <fpage>175</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1007/s10384-011-0106-3</pub-id><pub-id pub-id-type="pmid">22183138</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikorska</surname><given-names>M.</given-names></name><name><surname>Sandhu</surname><given-names>J. K.</given-names></name><name><surname>Simon</surname><given-names>D. K.</given-names></name><name><surname>Pathiraja</surname><given-names>V.</given-names></name><name><surname>Sodja</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Identification of ataxia-associated mtDNA mutations (m.4052T&gt;C and m.9035T&gt;C) and evaluation of their pathogenicity in transmitochondrial cybrids</article-title>. <source/>Muscle Nerve
<volume>40</volume>, <fpage>381</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1002/mus.21355</pub-id><pub-id pub-id-type="pmid">19626676</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skladal</surname><given-names>D.</given-names></name><name><surname>Halliday</surname><given-names>J.</given-names></name><name><surname>Thorburn</surname><given-names>D. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Minimum birth prevalence of mitochondrial respiratory chain disorders in children</article-title>. <source/>Brain
<volume>126</volume>, <fpage>1905</fpage>–<lpage>1912</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awg170</pub-id><pub-id pub-id-type="pmid">12805096</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobti</surname><given-names>M.</given-names></name><name><surname>Smits</surname><given-names>C.</given-names></name><name><surname>Wong</surname><given-names>A. S.</given-names></name><name><surname>Ishmukhametov</surname><given-names>R.</given-names></name><name><surname>Stock</surname><given-names>D.</given-names></name><name><surname>Sandin</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Cryo-EM structures of the autoinhibited <italic>E. coli</italic> ATP synthase in three rotational states</article-title>. <source/>Elife
<volume>5</volume>:<fpage>e21598</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.21598</pub-id><pub-id pub-id-type="pmid">28001127</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinmetz</surname><given-names>L. M.</given-names></name><name><surname>Scharfe</surname><given-names>C.</given-names></name><name><surname>Deutschbauer</surname><given-names>A. M.</given-names></name><name><surname>Mokranjac</surname><given-names>D.</given-names></name><name><surname>Herman</surname><given-names>Z. S.</given-names></name><name><surname>Jones</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Systematic screen for human disease genes in yeast</article-title>. <source/>Nat. Genet.
<volume>31</volume>, <fpage>400</fpage>–<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1038/ng929</pub-id><pub-id pub-id-type="pmid">12134146</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>J. B.</given-names></name><name><surname>Chinnery</surname><given-names>P. F.</given-names></name></person-group> (<year>2015</year>). <article-title>The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease</article-title>. <source/>Nat. Rev. Genet.
<volume>16</volume>, <fpage>530</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3966</pub-id><pub-id pub-id-type="pmid">26281784</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>M.</given-names></name><name><surname>Hofhaus</surname><given-names>G.</given-names></name><name><surname>Schroder</surname><given-names>R. R.</given-names></name><name><surname>Kuhlbrandt</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Dimer ribbons of ATP synthase shape the inner mitochondrial membrane</article-title>. <source/>EMBO J.
<volume>27</volume>, <fpage>1154</fpage>–<lpage>1160</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2008.35</pub-id><pub-id pub-id-type="pmid">18323778</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swalwell</surname><given-names>H.</given-names></name><name><surname>Blakely</surname><given-names>E. L.</given-names></name><name><surname>Sutton</surname><given-names>R.</given-names></name><name><surname>Tonska</surname><given-names>K.</given-names></name><name><surname>Elstner</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?</article-title>
<source/>Eur. J. Hum. Genet.
<volume>16</volume>, <fpage>1265</fpage>–<lpage>1274</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.65</pub-id><pub-id pub-id-type="pmid">18398437</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synofzik</surname><given-names>M.</given-names></name><name><surname>Schicks</surname><given-names>J.</given-names></name><name><surname>Wilhelm</surname><given-names>C.</given-names></name><name><surname>Bornemann</surname><given-names>A.</given-names></name><name><surname>Schols</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Charcot-marie-tooth hereditary neuropathy due to a mitochondrial ATP6 mutation</article-title>. <source/>Eur. J. Neurol.
<volume>19</volume>, <fpage>e114</fpage>–<lpage>e116</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2012.03812.x</pub-id><pub-id pub-id-type="pmid">22971232</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Batra</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ebenroth</surname><given-names>E. S.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Left ventricular noncompaction is associated with mutations in the mitochondrial genome</article-title>. <source/>Mitochondrion
<volume>10</volume>, <fpage>350</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.02.003</pub-id><pub-id pub-id-type="pmid">20211276</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>V. W.</given-names></name><name><surname>Li</surname><given-names>F. Y.</given-names></name><name><surname>Landsverk</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects</article-title>. <source/>Hum. Mutat.
<volume>34</volume>, <fpage>882</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22307</pub-id><pub-id pub-id-type="pmid">23463613</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tansel</surname><given-names>T.</given-names></name><name><surname>Pacal</surname><given-names>F.</given-names></name><name><surname>Ustek</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>A novel ATP8 gene mutation in an infant with tetralogy of Fallot</article-title>. <source/>Cardiol. Young
<volume>24</volume>, <fpage>531</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1017/S1047951113000668</pub-id><pub-id pub-id-type="pmid">23735083</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatuch</surname><given-names>Y.</given-names></name><name><surname>Christodoulou</surname><given-names>J.</given-names></name><name><surname>Feigenbaum</surname><given-names>A.</given-names></name><name><surname>Clarke</surname><given-names>J. T.</given-names></name><name><surname>Wherret</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title>Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high</article-title>. <source/>Am. J. Hum. Genet.
<volume>50</volume>, <fpage>852</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="pmid">1550128</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thyagarajan</surname><given-names>D.</given-names></name><name><surname>Shanske</surname><given-names>S.</given-names></name><name><surname>Vazquez-Memije</surname><given-names>M.</given-names></name><name><surname>De Vivo</surname><given-names>D.</given-names></name><name><surname>Dimauro</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis</article-title>. <source/>Ann. Neurol.
<volume>38</volume>, <fpage>468</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410380321</pub-id><pub-id pub-id-type="pmid">7668837</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trounce</surname><given-names>I.</given-names></name><name><surname>Neill</surname><given-names>S.</given-names></name><name><surname>Wallace</surname><given-names>D. C.</given-names></name></person-group> (<year>1994</year>). <article-title>Cytoplasmic transfer of the mtDNA nt 8993 T→G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>91</volume>, <fpage>8334</fpage>–<lpage>8338</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.18.8334</pub-id><pub-id pub-id-type="pmid">8078883</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>J. D.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name><name><surname>Tsao</surname><given-names>T. F.</given-names></name><name><surname>Sheu</surname><given-names>J. N.</given-names></name></person-group> (<year>2012</year>). <article-title>A novel mitochondrial DNA 8597T&gt;C mutation of Leigh syndrome: report of one case</article-title>. <source/>Pediatr. Neonatol.
<volume>53</volume>, <fpage>60</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.pedneo.2011.11.012</pub-id><pub-id pub-id-type="pmid">22348497</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuppen</surname><given-names>H. A.</given-names></name><name><surname>Blakely</surname><given-names>E. L.</given-names></name><name><surname>Turnbull</surname><given-names>D. M.</given-names></name><name><surname>Taylor</surname><given-names>R. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial DNA mutations and human disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1797</volume>, <fpage>113</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2009.09.005</pub-id><pub-id pub-id-type="pmid">19761752</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H.</given-names></name><name><surname>Nishigaki</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>Q. P.</given-names></name><name><surname>Fuku</surname><given-names>N.</given-names></name><name><surname>Kojima</surname><given-names>S.</given-names></name><name><surname>Iwata</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia</article-title>. <source/>Mitochondrion
<volume>9</volume>, <fpage>385</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2009.06.003</pub-id><pub-id pub-id-type="pmid">19563917</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uziel</surname><given-names>G.</given-names></name><name><surname>Moroni</surname><given-names>I.</given-names></name><name><surname>Lamantea</surname><given-names>E.</given-names></name><name><surname>Fratta</surname><given-names>G. M.</given-names></name><name><surname>Ciceri</surname><given-names>E.</given-names></name><name><surname>Carrara</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families</article-title>. <source/>J. Neurol. Neurosurg. Psychiatr.
<volume>63</volume>, <fpage>16</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.63.1.16</pub-id><pub-id pub-id-type="pmid">9221962</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vafai</surname><given-names>S. B.</given-names></name><name><surname>Mootha</surname><given-names>V. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial disorders as windows into an ancient organelle</article-title>. <source/>Nature
<volume>491</volume>, <fpage>374</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1038/nature11707</pub-id><pub-id pub-id-type="pmid">23151580</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazquez-Memije</surname><given-names>M. E.</given-names></name><name><surname>Shanske</surname><given-names>S.</given-names></name><name><surname>Santorelli</surname><given-names>F. M.</given-names></name><name><surname>Kranz-Eble</surname><given-names>P.</given-names></name><name><surname>Devivo</surname><given-names>D. C.</given-names></name><name><surname>Dimauro</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Comparative biochemical studies of ATPases in cells from patients with the T8993G or T8993C mitochondrial DNA mutations</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>21</volume>, <fpage>829</fpage>–<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1023/A:1005418718299</pub-id><pub-id pub-id-type="pmid">9870208</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatesh</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Kriplani</surname><given-names>A.</given-names></name><name><surname>Ammini</surname><given-names>A. C.</given-names></name><name><surname>Talwar</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Oxidative stress and ATPase6 mutation is associated with primary ovarian insufficiency</article-title>. <source/>Arch. Gynecol. Obstet.
<volume>282</volume>, <fpage>313</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1007/s00404-010-1444-y</pub-id><pub-id pub-id-type="pmid">20361200</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verny</surname><given-names>C.</given-names></name><name><surname>Guegen</surname><given-names>N.</given-names></name><name><surname>Desquiret</surname><given-names>V.</given-names></name><name><surname>Chevrollier</surname><given-names>A.</given-names></name><name><surname>Prundean</surname><given-names>A.</given-names></name><name><surname>Dubas</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation</article-title>. <source/>Mitochondrion
<volume>11</volume>, <fpage>70</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.07.006</pub-id><pub-id pub-id-type="pmid">20656066</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vik</surname><given-names>S. B.</given-names></name><name><surname>Antonio</surname><given-names>B. J.</given-names></name></person-group> (<year>1994</year>). <article-title>A mechanism of proton translocation by F<sub>1</sub>F<sub>o</sub> ATP synthases suggested by double mutants of the a subunit</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>30364</fpage>–<lpage>30369</lpage>.<pub-id pub-id-type="pmid">7982950</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilarinho</surname><given-names>L.</given-names></name><name><surname>Barbot</surname><given-names>C.</given-names></name><name><surname>Carrozzo</surname><given-names>R.</given-names></name><name><surname>Calado</surname><given-names>E.</given-names></name><name><surname>Tessa</surname><given-names>A.</given-names></name><name><surname>Dionisi-Vici</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Clinical and molecular findings in four new patients harbouring the mtDNA 8993T&gt;C mutation</article-title>. <source/>J. Inherit. Metab. Dis.
<volume>24</volume>, <fpage>883</fpage>–<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1023/A:1013908728445</pub-id><pub-id pub-id-type="pmid">11916326</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>D. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial DNA mutations in disease and aging</article-title>. <source/>Environ. Mol. Mutagen.
<volume>51</volume>, <fpage>440</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1002/em.20586</pub-id><pub-id pub-id-type="pmid">20544884</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>S. M.</given-names></name><name><surname>El-Hassan</surname><given-names>N.</given-names></name><name><surname>Kahler</surname><given-names>S. G.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>Y. W.</given-names></name><name><surname>Miller</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes</article-title>. <source/>J. Med. Genet.
<volume>46</volume>, <fpage>308</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.063149</pub-id><pub-id pub-id-type="pmid">19188198</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehrle</surname><given-names>F.</given-names></name><name><surname>Kaim</surname><given-names>G.</given-names></name><name><surname>Dimroth</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular mechanism of the ATP synthase's F<sub>o</sub> motor probed by mutational analyses of subunit a</article-title>. <source/>J. Mol. Biol.
<volume>322</volume>, <fpage>369</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(02)00731-3</pub-id><pub-id pub-id-type="pmid">12217697</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Niedzwiecka</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Identification of G8969&gt;A in mitochondrial ATP6 gene that severely compromises ATP synthase function in a patient with IgA nephropathy</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>36313</fpage>. <pub-id pub-id-type="doi">10.1038/srep36313</pub-id><pub-id pub-id-type="pmid">27812026</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Pagadala</surname><given-names>V.</given-names></name><name><surname>Mueller</surname><given-names>D. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Understanding structure, function, and mutations in the mitochondrial ATP synthase</article-title>. <source/>Microb. Cell
<volume>2</volume>, <fpage>105</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.15698/mic2015.04.197</pub-id><pub-id pub-id-type="pmid">25938092</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>A novel heteroplasmic mitochondrial DNA mutation, A8890G, in a patient with juvenileonset metabolic syndrome: a case report</article-title>. <source/>Mol. Med. Rep.
<volume>8</volume>, <fpage>1060</fpage>–<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2013.1616</pub-id><pub-id pub-id-type="pmid">23921547</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeviani</surname><given-names>M.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>Mitochondrial disorders</article-title>. <source/>Curr. Opin. Neurol.
<volume>20</volume>, <fpage>564</fpage>–<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e3282ef58cd</pub-id><pub-id pub-id-type="pmid">17885446</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>A.</given-names></name><name><surname>Rohou</surname><given-names>A.</given-names></name><name><surname>Schep</surname><given-names>D. G.</given-names></name><name><surname>Bason</surname><given-names>J. V.</given-names></name><name><surname>Montgomery</surname><given-names>M. G.</given-names></name><name><surname>Walker</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Structure and conformational states of the bovine mitochondrial ATP synthase by cryo-EM</article-title>. <source/>Elife
<volume>4</volume>:<fpage>e10180</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.10180</pub-id><pub-id pub-id-type="pmid">26439008</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>